biomarker_id biomarker assessed_biomarker_entity assessed_biomarker_entity_id assessed_entity_type condition condition_id exposure_agent exposure_agent_id best_biomarker_role specimen specimen_id loinc_code evidence_source evidence tag vocab_pattern biomarker_controlled_vocab component_group flags BB1536-1 ABL1:E255K ABL1 NCBI:25 gene chronic myelogenous leukemia, BCR-ABL1 positive MONDO:0011996 PubMed:21562040 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::e255k sequence variation in gene ABL1/NCBI:25 2 check_entity BB1537-1 ABL1:F359V ABL1 NCBI:25 gene chronic myelogenous leukemia, BCR-ABL1 positive MONDO:0011996 PubMed:21562040 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::f359v sequence variation in gene ABL1/NCBI:25 3 check_entity BB1538-1 ABL1:I242T ABL1 NCBI:25 gene chronic myelogenous leukemia, BCR-ABL1 positive MONDO:0011996 PubMed:21562040 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::i242t sequence variation in gene ABL1/NCBI:25 4 check_entity BB1539-1 ABL1:T315A ABL1 NCBI:25 gene chronic myelogenous leukemia, BCR-ABL1 positive MONDO:0011996 PubMed:21562040 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::t315a sequence variation in gene ABL1/NCBI:25 5 check_entity BB1540-1 ABL1:T315I ABL1 NCBI:25 gene chronic myelogenous leukemia, BCR-ABL1 positive MONDO:0011996 PubMed:21562040 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::t315i sequence variation in gene ABL1/NCBI:25 6 check_entity BB1540-2 ABL1:T315I ABL1 NCBI:25 gene cancer MONDO:0004992 PubMed:25686603 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::t315i sequence variation in gene ABL1/NCBI:25 7 check_entity BB1541-1 ABL1:V299L ABL1 NCBI:25 gene cancer MONDO:0004992 PubMed:26924578 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::v299l sequence variation in gene ABL1/NCBI:25 8 check_entity BB1541-2 ABL1:V299L ABL1 NCBI:25 gene chronic myelogenous leukemia, BCR-ABL1 positive MONDO:0011996 PubMed:21562040 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::v299l sequence variation in gene ABL1/NCBI:25 9 check_entity BB1542-2 ABL1-BCR fusion ABL1 NCBI:25 gene acute lymphoblastic leukemia (disease) MONDO:0004967 PubMed:27582059 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::abl1-bcr:fusion sequence variation in gene ABL1/NCBI:25 11 check_entity BB1543-1 AKT1:E17K AKT1 NCBI:207 gene endometrial cancer MONDO:0011962 PubMed:27016228 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::e17k sequence variation in gene AKT1/NCBI:207 12 check_entity BB1543-2 AKT1:E17K AKT1 NCBI:207 gene cancer MONDO:0004992 PubMed:21464312 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::e17k sequence variation in gene AKT1/NCBI:207 13 check_entity BB1545-1 AKT1:Q79K AKT1 NCBI:207 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:24265152 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::Q79K sequence variation in gene AKT1/NCBI:207 15 check_entity BB1546-1 AKT3 fusion AKT3 NCBI:10000 gene breast adenocarcinoma MONDO:0004988 PubMed:22722202 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene AKT3/NCBI:10000 17 check_entity BB1547-1 ALK oncogenic mutation ALK NCBI:238 gene non-small cell lung carcinoma (disease) MONDO:0005233 PubMed:22235099 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene ALK/NCBI:238 18 check_entity BB1548-1 1151T ALK NCBI:238 gene lung adenocarcinoma MONDO:0005061 PubMed:22277784 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition 1151T [biomarker_term_in_review] 19 not_mapped BB1548-1 1151T ALK NCBI:238 gene lung adenocarcinoma MONDO:0005061 PubMed:24670165 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition 1151T [biomarker_term_in_review] 19 not_mapped BB1549-1 ALK:C1156Y ALK NCBI:238 gene lung adenocarcinoma MONDO:0005061 PubMed:27401242 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::C1156Y sequence variation in gene ALK/NCBI:238 20 check_entity BB1549-2 ALK:C1156Y ALK NCBI:238 gene non-small cell lung carcinoma (disease) MONDO:0005233 PubMed:20979473 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::C1156Y sequence variation in gene ALK/NCBI:238 21 check_entity BB1551-1 ALK:F1174L ALK NCBI:238 gene malignant glioma MONDO:0015917 PubMed:22072639 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::F1174L sequence variation in gene ALK/NCBI:238 23 check_entity BB1551-2 ALK:F1174L ALK NCBI:238 gene lung adenocarcinoma MONDO:0005061 PubMed:24327273 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::F1174L sequence variation in gene ALK/NCBI:238 24 check_entity BB1552-1 ALK:F856S ALK NCBI:238 gene acute myeloid leukemia MONDO:0018874 PubMed:26032424 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::F856S sequence variation in gene ALK/NCBI:238 25 check_entity BB1553-1 ALK:G1123S ALK NCBI:238 gene lung adenocarcinoma MONDO:0005061 PubMed:26134233 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::G1123S sequence variation in gene ALK/NCBI:238 26 check_entity BB1554-1 ALK:I1171T ALK NCBI:238 gene lung adenocarcinoma MONDO:0005061 PubMed:25228534 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::I1171T sequence variation in gene ALK/NCBI:238 27 check_entity BB1555-1 ALK:L1196M ALK NCBI:238 gene lung adenocarcinoma MONDO:0005061 PubMed:22277784 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::L1196M sequence variation in gene ALK/NCBI:238 28 check_entity BB1555-1 ALK:L1196M ALK NCBI:238 gene lung adenocarcinoma MONDO:0005061 PubMed:24670165 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::L1196M sequence variation in gene ALK/NCBI:238 28 check_entity BB1556-1 ALK:L1198F ALK NCBI:238 gene lung adenocarcinoma MONDO:0005061 PubMed:26698910 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::L1198F sequence variation in gene ALK/NCBI:238 29 check_entity BB1557-1 ALK:R1275Q ALK NCBI:238 gene malignant glioma MONDO:0015917 PubMed:22072639 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::R1275Q sequence variation in gene ALK/NCBI:238 30 check_entity AN4668-2 ALK amplification ALK NCBI:238 gene non-small cell lung carcinoma (disease) MONDO:0005233 PubMed:22235099 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene ALK/NCBI:238 31 AN4668-3 ALK amplification ALK NCBI:238 gene lung adenocarcinoma MONDO:0005061 PubMed:22277784 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene ALK/NCBI:238 32 AN4680-13 ALK fusion ALK NCBI:238 gene Lymphoma;Glioblastoma MONDO:0005062 PubMed:24491302 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene ALK/NCBI:238 34 check_entity AN4680-15 ALK fusion ALK NCBI:238 gene Colorectal adenocarcinoma;Inflammatory myofibroblastic MONDO:0005008 PubMed:26633560 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene ALK/NCBI:238 36 check_entity AN4680-15 ALK fusion ALK NCBI:238 gene colorectal adenocarcinoma MONDO:0005008 PubMed:26633560 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene ALK/NCBI:238 36 check_entity AN4680-14 ALK fusion ALK NCBI:238 gene lung adenocarcinoma MONDO:0005061 PubMed:25173427 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene ALK/NCBI:238 35 check_entity AN4680-14 ALK fusion ALK NCBI:238 gene lung adenocarcinoma MONDO:0005061 PubMed:26301689 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene ALK/NCBI:238 35 check_entity AN4680-14 ALK fusion ALK NCBI:238 gene lung adenocarcinoma MONDO:0005061 PubMed:25394791 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene ALK/NCBI:238 35 check_entity AN4680-14 ALK fusion ALK NCBI:238 gene lung adenocarcinoma MONDO:0005061 PubMed:23553849 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene ALK/NCBI:238 35 check_entity AN4680-14 ALK fusion ALK NCBI:238 gene lung adenocarcinoma MONDO:0005061 PubMed:23639470 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene ALK/NCBI:238 35 check_entity AN4680-12 ALK fusion ALK NCBI:238 gene non-small cell lung carcinoma (disease) MONDO:0005233 PubMed:26951079 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene ALK/NCBI:238 33 check_entity BB1558-1 APC oncogenic mutation APC NCBI:324 gene colorectal adenocarcinoma MONDO:0005008 PubMed:22440753 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene APC/NCBI:324 37 check_entity BB1559-1 AR:F877L AR NCBI:367 gene prostate adenocarcinoma MONDO:0005082 PubMed:23779130 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::F877L sequence variation in gene AR/NCBI:367 38 check_entity BB1560-1 AR (F877L) + AR (T878A) AR NCBI:367 gene prostate adenocarcinoma MONDO:0005082 PubMed:27196756 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition AR (F877L) + AR (T878A) [biomarker_term_in_review] 39 not_mapped BB1561-1 AR:L702H AR NCBI:367 gene prostate adenocarcinoma MONDO:0005082 PubMed:26537258 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::L702H sequence variation in gene AR/NCBI:367 40 check_entity BB1562-1 AR:T878A AR NCBI:367 gene prostate adenocarcinoma MONDO:0005082 PubMed:2260966 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::T878A sequence variation in gene AR/NCBI:367 41 check_entity BB1563-1 AR amplification AR NCBI:367 gene prostate adenocarcinoma MONDO:0005082 PubMed:26537258 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene AR/NCBI:367 42 BB1563-1 AR amplification AR NCBI:367 gene prostate adenocarcinoma MONDO:0005082 PubMed:23589709 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene AR/NCBI:367 42 AN4703-2 AR overexpression AR NCBI:367 gene prostate adenocarcinoma MONDO:0005082 PubMed:24882673 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:expression Increased expression of gene AR/NCBI:367 43 BB1566-1 AREG amplification AREG NCBI:374 gene colorectal adenocarcinoma MONDO:0005008 PubMed:19738126 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene AREG/NCBI:374 47 BB1567-1 ARID1A oncogenic mutation ARID1A NCBI:8289 gene cancer MONDO:0004992 PubMed:27958275 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene ARID1A/NCBI:8289 48 check_entity BB1567-2 ARID1A oncogenic mutation ARID1A NCBI:8289 gene ovarian cancer MONDO:0008170 PubMed:25686104 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene ARID1A/NCBI:8289 49 check_entity BB1567-1 ARID1A oncogenic mutation ARID1A NCBI:8289 gene cancer MONDO:0004992 PubMed:26069190 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene ARID1A/NCBI:8289 48 check_entity BB1568-1 ARID1A oncogenic mutation + ANXA1 overexpression ARID1A NCBI:8289 gene breast adenocarcinoma MONDO:0004988 PubMed:27172896 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation:+:anxa1:overexpression sequence variation in gene ARID1A/NCBI:8289 50 check_entity BB1569-1 ARID1A amplification + ANXA1 overexpression ARID1A NCBI:8289 gene breast adenocarcinoma MONDO:0004988 PubMed:27172896 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition ARID1A amplification + ANXA1 overexpression [biomarker_term_in_review] 51 not_mapped BB1570-1 ATM oncogenic mutation ATM NCBI:472 gene childhood bladder carcinoma MONDO:0022578 PubMed:26238431 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene ATM/NCBI:472 52 check_entity BB1570-3 ATM oncogenic mutation ATM NCBI:472 gene malignant glioma MONDO:0015917 PubMed:23960094 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene ATM/NCBI:472 54 check_entity BB1570-5 ATM oncogenic mutation ATM NCBI:472 gene lymphoma MONDO:0005062 PubMed:23761041 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene ATM/NCBI:472 56 check_entity BB1571-1 ATM deletion ATM NCBI:472 gene childhood bladder carcinoma MONDO:0022578 PubMed:26238431 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene ATM/NCBI:472 57 check_entity BB1571-3 ATM deletion ATM NCBI:472 gene lymphoma MONDO:0005062 PubMed:23761041 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene ATM/NCBI:472 59 check_entity BB1572-1 ATR oncogenic mutation ATR NCBI:545 gene malignant glioma MONDO:0015917 PubMed:23960094 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene ATR/NCBI:545 61 check_entity BB1572-2 ATR oncogenic mutation ATR NCBI:545 gene Ovary;Any cancer type MONDO:0008170 PubMed:23548269 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene ATR/NCBI:545 62 check_entity BB1573-1 ATR deletion ATR NCBI:545 gene Ovary;Any cancer type MONDO:0008170 PubMed:23548269 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene ATR/NCBI:545 63 check_entity AN4743-2 AURKA amplification AURKA NCBI:6790 gene Prostate adenocarcinoma;Any cancer type MONDO:0005082 PubMed:22302096 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene AURKA/NCBI:6790 64 BB1574-1 B2M oncogenic mutation B2M NCBI:567 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:27433843 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::B2M sequence variation in gene B2M/NCBI:567 65 check_entity BB1575-1 BAP1 oncogenic mutation BAP1 NCBI:8314 gene benign mesothelioma MONDO:0002373 PubMed:26437366 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BAP1/NCBI:8314 66 check_entity BB1575-2 BAP1 oncogenic mutation BAP1 NCBI:8314 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:22038994 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BAP1/NCBI:8314 67 check_entity BB1575-3 BAP1 oncogenic mutation BAP1 NCBI:8314 gene Renal;Any cancer type MONDO:0004992 PubMed:22683710 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BAP1/NCBI:8314 68 check_entity BB1576-1 BAP1 deletion BAP1 NCBI:8314 gene benign mesothelioma MONDO:0002373 PubMed:26437366 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene BAP1/NCBI:8314 69 check_entity BB1576-2 BAP1 deletion BAP1 NCBI:8314 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:22038994 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene BAP1/NCBI:8314 70 check_entity BB1576-3 BAP1 deletion BAP1 NCBI:8314 gene Renal;Any cancer type MONDO:0004992 PubMed:22683710 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene BAP1/NCBI:8314 71 check_entity BB1577-1 BCL2 amplification BCL2 NCBI:596 gene lymphoma MONDO:0005062 PubMed:22649144 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene BCL2/NCBI:596 72 BB1579-1 BCOR oncogenic mutation BCOR NCBI:54880 gene gastric carcinoma MONDO:0004950 PubMed:27397505 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BCOR/NCBI:54880 75 check_entity BB1580-1 BRAF inframe deletion (L485),inframe deletion (P490) BRAF NCBI:673 gene cancer MONDO:0004992 PubMed:26732095 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::inframe:deletion:(l485),inframe:deletion:(p490) sequence variation in gene BRAF/NCBI:673 76 check_entity BB1581-1 BRAF:D594G BRAF NCBI:673 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:18794803 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::D594G sequence variation in gene BRAF/NCBI:673 77 check_entity BB1582-1 BRAF:G466V BRAF NCBI:673 gene lung adenocarcinoma MONDO:0005061 PubMed:22649091 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::G466V sequence variation in gene BRAF/NCBI:673 78 check_entity BB1583-1 BRAF (G469A) + EGFR oncogenic mutation BRAF NCBI:673 gene lung adenocarcinoma MONDO:0005061 PubMed:22773810 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::(g469a):+:egfr:oncogenic:mutation sequence variation in gene BRAF/NCBI:673 79 check_entity BB1584-1 BRAF:K601R BRAF NCBI:673 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23248257 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::K601R sequence variation in gene BRAF/NCBI:673 80 check_entity BB1586-1 BRAF:L597R BRAF NCBI:673 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23715574 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::L597R sequence variation in gene BRAF/NCBI:673 82 check_entity BB1587-1 BRAF (V600) BRAF NCBI:673 gene colorectal adenocarcinoma MONDO:0005008 PubMed:26287849 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition BRAF (V600) [biomarker_term_in_review] 83 not_mapped BB1587-1 BRAF (V600) BRAF NCBI:673 gene colorectal adenocarcinoma MONDO:0005008 PubMed:27729313 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition BRAF (V600) [biomarker_term_in_review] 83 not_mapped BB1587-1 BRAF (V600) BRAF NCBI:673 gene colorectal adenocarcinoma MONDO:0005008 PubMed:28363909 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition BRAF (V600) [biomarker_term_in_review] 83 not_mapped AN4810-2 BRAF:V600E BRAF NCBI:673 gene colorectal adenocarcinoma MONDO:0005008 PubMed:20619739 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V600E sequence variation in gene BRAF/NCBI:673 85 check_entity AN4810-5 BRAF:V600E BRAF NCBI:673 gene anaplastic astrocytoma MONDO:0016684 PubMed:22586120 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V600E sequence variation in gene BRAF/NCBI:673 88 check_entity AN4810-6 BRAF:V600E BRAF NCBI:673 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:23470635 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V600E sequence variation in gene BRAF/NCBI:673 89 check_entity AN4810-7 BRAF:V600E BRAF NCBI:673 gene Lung adenocarcinoma;Thyroid MONDO:0005061 PubMed:23524406 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V600E sequence variation in gene BRAF/NCBI:673 90 check_entity AN4810-2 BRAF:V600E BRAF NCBI:673 gene colorectal adenocarcinoma MONDO:0005008 PubMed:26392102 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V600E sequence variation in gene BRAF/NCBI:673 85 check_entity AN4810-7 BRAF:V600E BRAF NCBI:673 gene lung adenocarcinoma MONDO:0005061 PubMed:27283860 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V600E sequence variation in gene BRAF/NCBI:673 90 check_entity AN4810-7 BRAF:V600E BRAF NCBI:673 gene Lung adenocarcinoma;Hairy-Cell leukemia;Myeloma MONDO:0005061 PubMed:22743296 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V600E sequence variation in gene BRAF/NCBI:673 90 check_entity AN4810-4 BRAF:V600E BRAF NCBI:673 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:22997239 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V600E sequence variation in gene BRAF/NCBI:673 87 check_entity AN4810-4 BRAF:V600E BRAF NCBI:673 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:22351686 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V600E sequence variation in gene BRAF/NCBI:673 87 check_entity AN4810-4 BRAF:V600E BRAF NCBI:673 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:22389471 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V600E sequence variation in gene BRAF/NCBI:673 87 check_entity AN4810-9 BRAF:V600E BRAF NCBI:673 gene ovarian cancer MONDO:0008170 PubMed:22608338 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V600E sequence variation in gene BRAF/NCBI:673 92 check_entity AN4810-10 BRAF:V600E BRAF NCBI:673 gene malignant glioma MONDO:0015917 PubMed:22038996 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V600E sequence variation in gene BRAF/NCBI:673 93 check_entity AN4810-4 BRAF:V600E BRAF NCBI:673 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23614898 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V600E sequence variation in gene BRAF/NCBI:673 87 check_entity AN4810-8 BRAF:V600E BRAF NCBI:673 gene thyroid cancer MONDO:0002108 PubMed:22241789 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V600E sequence variation in gene BRAF/NCBI:673 91 check_entity AN4810-9 BRAF:V600E BRAF NCBI:673 gene ovarian cancer MONDO:0008170 PubMed:19018267 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V600E sequence variation in gene BRAF/NCBI:673 92 check_entity AN4810-7 BRAF:V600E BRAF NCBI:673 gene lung adenocarcinoma MONDO:0005061 PubMed:22773810 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V600E sequence variation in gene BRAF/NCBI:673 90 check_entity AN4810-3 BRAF:V600E BRAF NCBI:673 gene Non-small cell lung;Lagerhans cell histiocytosis;Erdheim-Chester histiocytosis MONDO:0005233 PubMed:26287849 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V600E sequence variation in gene BRAF/NCBI:673 86 check_entity BB1589-1 BRAF:V600R BRAF NCBI:673 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23237741 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V600R sequence variation in gene BRAF/NCBI:673 94 check_entity BB1590-1 BRAF:Y472C BRAF NCBI:673 gene lung adenocarcinoma MONDO:0005061 PubMed:22649091 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::Y472C sequence variation in gene BRAF/NCBI:673 95 check_entity BB1591-1 BRAF fusion BRAF NCBI:673 gene ovarian cancer MONDO:0008170 PubMed:26324360 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene BRAF/NCBI:673 96 check_entity BB1591-2 BRAF fusion BRAF NCBI:673 gene Cutaneous melanoma;Lung adenocarcinoma;Prostate adenocarcinoma MONDO:0005012 PubMed:238900088 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene BRAF/NCBI:673 97 check_entity BB1591-3 BRAF fusion BRAF NCBI:673 gene Lung adenocarcinoma;Cutaneous melanoma;Prostate adenocarcinoma MONDO:0005061 PubMed:24727320 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene BRAF/NCBI:673 98 check_entity BB1592-1 BRCA1 oncogenic mutation BRCA1 NCBI:672 gene prostate adenocarcinoma MONDO:0005082 PubMed:26510020 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BRCA1/NCBI:672 99 check_entity BB1592-3 BRCA1 oncogenic mutation BRCA1 NCBI:672 gene breast adenocarcinoma MONDO:0004988 PubMed:25847936 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BRCA1/NCBI:672 101 check_entity BB1592-2 BRCA1 oncogenic mutation BRCA1 NCBI:672 gene ovarian cancer MONDO:0008170 PubMed:22406760 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BRCA1/NCBI:672 100 check_entity BB1592-3 BRCA1 oncogenic mutation BRCA1 NCBI:672 gene breast adenocarcinoma MONDO:0004988 PubMed:26801247 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BRCA1/NCBI:672 101 check_entity BB1592-2 BRCA1 oncogenic mutation BRCA1 NCBI:672 gene ovarian cancer MONDO:0008170 PubMed:22307137 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BRCA1/NCBI:672 100 check_entity BB1592-4 BRCA1 oncogenic mutation BRCA1 NCBI:672 gene exocrine pancreatic carcinoma MONDO:0005192 PubMed:25366685 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BRCA1/NCBI:672 102 check_entity BB1592-5 BRCA1 oncogenic mutation BRCA1 NCBI:672 gene cancer MONDO:0004992 PubMed:25964244 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BRCA1/NCBI:672 103 check_entity BB1592-3 BRCA1 oncogenic mutation BRCA1 NCBI:672 gene breast adenocarcinoma MONDO:0004988 PubMed:20609467 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BRCA1/NCBI:672 101 check_entity BB1593-1 BRCA1 deletion BRCA1 NCBI:672 gene ovarian cancer MONDO:0008170 PubMed:22392482 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene BRCA1/NCBI:672 104 check_entity BB1594-1 BRCA2 oncogenic mutation BRCA2 NCBI:675 gene breast adenocarcinoma MONDO:0004988 PubMed:20609467 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BRCA2/NCBI:675 105 check_entity BB1594-3 BRCA2 oncogenic mutation BRCA2 NCBI:675 gene exocrine pancreatic carcinoma MONDO:0005192 PubMed:25719666 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BRCA2/NCBI:675 107 check_entity BB1594-1 BRCA2 oncogenic mutation BRCA2 NCBI:675 gene breast adenocarcinoma MONDO:0004988 PubMed:25847936 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BRCA2/NCBI:675 105 check_entity BB1594-2 BRCA2 oncogenic mutation BRCA2 NCBI:675 gene ovarian cancer MONDO:0008170 PubMed:22406760 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BRCA2/NCBI:675 106 check_entity BB1594-1 BRCA2 oncogenic mutation BRCA2 NCBI:675 gene breast adenocarcinoma MONDO:0004988 PubMed:26801247 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BRCA2/NCBI:675 105 check_entity BB1594-2 BRCA2 oncogenic mutation BRCA2 NCBI:675 gene ovarian cancer MONDO:0008170 PubMed:22307137 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BRCA2/NCBI:675 106 check_entity BB1594-4 BRCA2 oncogenic mutation BRCA2 NCBI:675 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:26997480 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BRCA2/NCBI:675 108 check_entity BB1594-5 BRCA2 oncogenic mutation BRCA2 NCBI:675 gene prostate adenocarcinoma MONDO:0005082 PubMed:26510020 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene BRCA2/NCBI:675 109 check_entity BB1595-1 BRCA2 deletion BRCA2 NCBI:675 gene ovarian cancer MONDO:0008170 PubMed:22392482 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene BRCA2/NCBI:675 110 check_entity BB1597-1 BTK (C481) BTK NCBI:695 gene mantle cell lymphoma MONDO:0018876 PubMed:25082755 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition BTK (C481) [biomarker_term_in_review] 111 not_mapped BB1598-1 BTK:C481S BTK NCBI:695 gene B-cell chronic lymphocytic leukemia MONDO:0004948 PubMed:24869598 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::C481S sequence variation in gene BTK/NCBI:695 112 check_entity AN4853-8 CCND1 amplification CCND1 NCBI:595 gene medulloblastoma MONDO:0007959 PubMed:24951114 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene CCND1/NCBI:595 114 AN4853-10 CCND1 amplification CCND1 NCBI:595 gene cancer MONDO:0004992 PubMed:22471707 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene CCND1/NCBI:595 116 AN4856-3 CCND2 amplification CCND2 NCBI:894 gene cancer MONDO:0004992 PubMed:22471707 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene CCND2/NCBI:894 118 AN4859-2 CCND3 amplification CCND3 NCBI:896 gene cancer MONDO:0004992 PubMed:22471707 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene CCND3/NCBI:896 119 AN4861-4 CCNE1 amplification CCNE1 NCBI:898 gene cancer MONDO:0004992 PubMed:22471707 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene CCNE1/NCBI:898 120 BB1599-1 CD274 amplification CD274 NCBI:29126 gene skin basal cell carcinoma MONDO:0005341 PubMed:27942391 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene CD274/NCBI:29126 121 BB1599-2 CD274 amplification CD274 NCBI:29126 gene cancer MONDO:0004992 PubMed:25079317 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene CD274/NCBI:29126 122 BB1601-1 CD69 undexpression CD69 NCBI:969 gene B-cell chronic lymphocytic leukemia MONDO:0004948 PubMed:26701728 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition CD69 undexpression [biomarker_term_in_review] 125 not_mapped BB1602-1 CDH1 oncogenic mutation CDH1 NCBI:999 gene breast adenocarcinoma MONDO:0004988 PubMed:27397505 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene CDH1/NCBI:999 126 check_entity BB1603-1 CDK12 oncogenic mutation CDK12 NCBI:51755 gene ovarian cancer MONDO:0008170 PubMed:24240700 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene CDK12/NCBI:51755 127 check_entity BB1604-1 CDK12 amplification CDK12 NCBI:51755 gene ovarian cancer MONDO:0008170 PubMed:24240700 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene CDK12/NCBI:51755 128 BB1606-1 CDK4 amplification + RB1 expression CDK4 NCBI:1019 gene liposarcoma MONDO:0005060 PubMed:23569312 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition CDK4 amplification + RB1 expression [biomarker_term_in_review] 132 not_mapped BB1608-2 CDK6 amplification CDK6 NCBI:1021 gene cancer MONDO:0004992 PubMed:22471707 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene CDK6/NCBI:1021 135 BB1609-1 CDKN1A oncogenic mutation CDKN1A NCBI:1026 gene cancer MONDO:0004992 PubMed:22471707 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene CDKN1A/NCBI:1026 136 check_entity BB1610-1 CDKN1A deletion CDKN1A NCBI:1026 gene cancer MONDO:0004992 PubMed:22471707 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene CDKN1A/NCBI:1026 137 check_entity BB1611-1 CDKN1B oncogenic mutation CDKN1B NCBI:1027 gene cancer MONDO:0004992 PubMed:22471707 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene CDKN1B/NCBI:1027 138 check_entity BB1612-1 CDKN1B deletion CDKN1B NCBI:1027 gene cancer MONDO:0004992 PubMed:22471707 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene CDKN1B/NCBI:1027 139 check_entity BB1613-3 CDKN2A oncogenic mutation CDKN2A NCBI:1029 gene Glioma;Any cancer type MONDO:0015917 PubMed:22471707 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene CDKN2A/NCBI:1029 142 check_entity AN4879-4 CDKN2A deletion CDKN2A NCBI:1029 gene Glioma;Any cancer type MONDO:0015917 PubMed:22471707 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene CDKN2A/NCBI:1029 145 check_entity BB1614-1 CDKN2B oncogenic mutation CDKN2B NCBI:1030 gene Glioma;Any cancer type MONDO:0015917 PubMed:22471707 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene CDKN2B/NCBI:1030 146 check_entity BB1615-1 CDKN2B deletion CDKN2B NCBI:1030 gene Glioma;Any cancer type MONDO:0015917 PubMed:22471707 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene CDKN2B/NCBI:1030 147 check_entity BB1616-1 CDKN2C oncogenic mutation CDKN2C NCBI:1031 gene Glioma;Any cancer type MONDO:0015917 PubMed:22471707 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene CDKN2C/NCBI:1031 148 check_entity BB1617-1 CDKN2C deletion CDKN2C NCBI:1031 gene Glioma;Any cancer type MONDO:0015917 PubMed:22471707 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene CDKN2C/NCBI:1031 149 check_entity BB1618-1 CHEK2 oncogenic mutation CHEK2 NCBI:11200 gene prostate adenocarcinoma MONDO:0005082 PubMed:26510020 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene CHEK2/NCBI:11200 150 check_entity BB1620-1 CRBN oncogenic mutation CRBN NCBI:51185 gene myeloid neoplasm MONDO:0005170 PubMed:25108355 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene CRBN/NCBI:51185 152 check_entity BB1621-1 CRBN:Q100* CRBN NCBI:51185 gene myeloid neoplasm MONDO:0005170 PubMed:23480694 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::Q100* sequence variation in gene CRBN/NCBI:51185 153 check_entity BB1622-1 CRBN undexpression CRBN NCBI:51185 gene myeloid neoplasm MONDO:0005170 PubMed:21860026 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition CRBN undexpression [biomarker_term_in_review] 154 not_mapped BB1623-1 CRLF2 fusion CRLF2 NCBI:64109 gene acute lymphoblastic leukemia (disease) MONDO:0004967 PubMed:22904298 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene CRLF2/NCBI:64109 155 check_entity BB1623-1 CRLF2 fusion CRLF2 NCBI:64109 gene acute lymphoblastic leukemia (disease) MONDO:0004967 PubMed:22955920 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene CRLF2/NCBI:64109 155 check_entity BB1624-1 CSF3R frameshift variant (D771),frameshift variant (S783) CSF3R NCBI:1441 gene atypical chronic myeloid leukemia MONDO:0020312 PubMed:23656643 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition CSF3R frameshift variant (D771),frameshift variant (S783) [biomarker_term_in_review] 156 not_mapped BB1625-1 CTNNB1 oncogenic mutation CTNNB1 NCBI:1499 gene colorectal adenocarcinoma MONDO:0005008 PubMed:23539443 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene CTNNB1/NCBI:1499 157 check_entity BB1626-1 CTNNB1:H36Y CTNNB1 NCBI:1499 gene endometrial cancer MONDO:0011962 PubMed:25624430 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::H36Y sequence variation in gene CTNNB1/NCBI:1499 158 check_entity BB1627-1 CYP17A1 expression CYP17A1 NCBI:1586 gene prostate adenocarcinoma MONDO:0005082 PubMed:22184395 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;aspect_type:expression Presence of expression of gene CYP17A1/NCBI:1586 159 BB1627-1 CYP17A1 expression CYP17A1 NCBI:1586 gene prostate adenocarcinoma MONDO:0005082 PubMed:24882673 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;aspect_type:expression Presence of expression of gene CYP17A1/NCBI:1586 159 BB1628-1 DDR2:I638F DDR2 NCBI:4921 gene squamous cell lung carcinoma MONDO:0005097 PubMed:22328973 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::I638F sequence variation in gene DDR2/NCBI:4921 160 check_entity BB1629-1 DDR2:S768R DDR2 NCBI:4921 gene squamous cell lung carcinoma MONDO:0005097 PubMed:22328973 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::S768R sequence variation in gene DDR2/NCBI:4921 161 check_entity BB1630-1 DNMT3A oncogenic mutation DNMT3A NCBI:1788 gene acute myeloid leukemia MONDO:0018874 PubMed:22417203 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene DNMT3A/NCBI:1788 162 check_entity BB1631-1 DPYD biallelic inactivation DPYD NCBI:1806 gene cancer MONDO:0004992 PubMed:23988873 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition DPYD biallelic inactivation [biomarker_term_in_review] 163 not_mapped BB1632-1 DPYD splice donor variant DPYD NCBI:1806 gene cancer MONDO:0004992 PubMed:23988873 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition DPYD splice donor variant [biomarker_term_in_review] 164 not_mapped BB1633-1 DPYD:I560S DPYD NCBI:1806 gene cancer MONDO:0004992 PubMed:23988873 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::I560S sequence variation in gene DPYD/NCBI:1806 165 check_entity BB1634-1 EGFR inframe deletion (30-336) EGFR NCBI:1956 gene malignant glioma MONDO:0015917 PubMed:19204207 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::inframe:deletion:(30-336) sequence variation in gene EGFR/NCBI:1956 166 check_entity BB1637-1 EGFR exon 19 insertions EGFR NCBI:1956 gene lung cancer MONDO:0008903 PubMed:22753918 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::exon:19:insertions sequence variation in gene EGFR/NCBI:1956 170 check_entity BB1637-1 EGFR exon 19 insertions EGFR NCBI:1956 gene lung cancer MONDO:0008903 PubMed:22190593 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::exon:19:insertions sequence variation in gene EGFR/NCBI:1956 170 check_entity BB1637-1 EGFR exon 19 insertions EGFR NCBI:1956 gene lung cancer MONDO:0008903 PubMed:23102728 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::exon:19:insertions sequence variation in gene EGFR/NCBI:1956 170 check_entity BB1638-1 EGFR exon 20 insertions EGFR NCBI:1956 gene lung cancer MONDO:0008903 PubMed:21764376 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::exon:20:insertions sequence variation in gene EGFR/NCBI:1956 171 check_entity BB1638-1 EGFR exon 20 insertions EGFR NCBI:1956 gene lung cancer MONDO:0008903 PubMed:26515464 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::exon:20:insertions sequence variation in gene EGFR/NCBI:1956 171 check_entity BB1639-1 769-770 EGFR NCBI:1956 gene lung cancer MONDO:0008903 PubMed:26773740 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition 769-770 [biomarker_term_in_review] 172 not_mapped BB1640-1 EGFR:A289V EGFR NCBI:1956 gene malignant glioma MONDO:0015917 PubMed:17177598 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::A289V sequence variation in gene EGFR/NCBI:1956 173 check_entity BB1641-1 EGFR:C797S EGFR NCBI:1956 gene lung cancer MONDO:0008903 PubMed:25939061 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::C797S sequence variation in gene EGFR/NCBI:1956 174 check_entity BB1642-1 EGFR:D761Y EGFR NCBI:1956 gene non-small cell lung carcinoma (disease) MONDO:0005233 PubMed:19680293 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::D761Y sequence variation in gene EGFR/NCBI:1956 175 check_entity BB1643-1 EGFR:E690K EGFR NCBI:1956 gene endometrial cancer MONDO:0011962 PubMed:22885469 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::E690K sequence variation in gene EGFR/NCBI:1956 176 check_entity BB1644-1 EGFR:G465R EGFR NCBI:1956 gene colorectal adenocarcinoma MONDO:0005008 PubMed:26059438 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::G465R sequence variation in gene EGFR/NCBI:1956 177 check_entity BB1645-1 EGFR:K757R EGFR NCBI:1956 gene lung cancer MONDO:0008903 PubMed:26773740 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::K757R sequence variation in gene EGFR/NCBI:1956 178 check_entity BB1648-1 EGFR:L798I EGFR NCBI:1956 gene lung adenocarcinoma MONDO:0005061 PubMed:27283993 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::L798I sequence variation in gene EGFR/NCBI:1956 181 check_entity BB1649-1 EGFR:L858R EGFR NCBI:1956 gene lung cancer MONDO:0008903 PubMed:22753918 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::L858R sequence variation in gene EGFR/NCBI:1956 182 check_entity BB1649-1 EGFR:L858R EGFR NCBI:1956 gene lung cancer MONDO:0008903 PubMed:23102728 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::L858R sequence variation in gene EGFR/NCBI:1956 182 check_entity BB1652-1 EGFR:S464L EGFR NCBI:1956 gene colorectal adenocarcinoma MONDO:0005008 PubMed:25623215 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::S464L sequence variation in gene EGFR/NCBI:1956 186 check_entity BB1653-1 EGFR:S492R EGFR NCBI:1956 gene colorectal adenocarcinoma MONDO:0005008 PubMed:22270724 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::S492R sequence variation in gene EGFR/NCBI:1956 187 check_entity BB1653-1 EGFR:S492R EGFR NCBI:1956 gene colorectal adenocarcinoma MONDO:0005008 PubMed:25962717 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::S492R sequence variation in gene EGFR/NCBI:1956 187 check_entity BB1654-1 EGFR (S720) EGFR NCBI:1956 gene lung cancer MONDO:0008903 PubMed:26773740 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition EGFR (S720) [biomarker_term_in_review] 188 not_mapped BB1655-1 EGFR:T790M EGFR NCBI:1956 gene non-small cell lung carcinoma (disease) MONDO:0005233 PubMed:19680293 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::T790M sequence variation in gene EGFR/NCBI:1956 189 check_entity BB1655-1 EGFR:T790M EGFR NCBI:1956 gene non-small cell lung carcinoma (disease) MONDO:0005233 PubMed:22452896 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::T790M sequence variation in gene EGFR/NCBI:1956 189 check_entity BB1655-2 EGFR:T790M EGFR NCBI:1956 gene lung cancer MONDO:0008903 PubMed:25074459 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::T790M sequence variation in gene EGFR/NCBI:1956 190 check_entity BB1655-2 EGFR:T790M EGFR NCBI:1956 gene lung cancer MONDO:0008903 PubMed:26667485 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::T790M sequence variation in gene EGFR/NCBI:1956 190 check_entity AN4954-9 EGFR amplification EGFR NCBI:1956 gene malignant glioma MONDO:0015917 PubMed:16282176 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene EGFR/NCBI:1956 192 AN4954-10 EGFR amplification EGFR NCBI:1956 gene endometrial cancer MONDO:0011962 PubMed:24950987 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene EGFR/NCBI:1956 193 AN4954-11 EGFR amplification EGFR NCBI:1956 gene colorectal adenocarcinoma MONDO:0005008 PubMed:18794099 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene EGFR/NCBI:1956 194 BB1656-1 EGFR-RAD51 fusion EGFR NCBI:1956 gene non-small cell lung carcinoma (disease) MONDO:0005233 PubMed:27102076 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::egfr-rad51:fusion sequence variation in gene EGFR/NCBI:1956 196 check_entity BB1656-2 EGFR-RAD51 fusion EGFR NCBI:1956 gene lung cancer MONDO:0008903 PubMed:27102076 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::egfr-rad51:fusion sequence variation in gene EGFR/NCBI:1956 197 check_entity BB1657-1 EPHA2:G391R EPHA2 NCBI:1969 gene squamous cell lung carcinoma MONDO:0005097 PubMed:20360610 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::G391R sequence variation in gene EPHA2/NCBI:1969 198 check_entity BB1658-1 EPHA2 amplification EPHA2 NCBI:1969 gene cancer MONDO:0004992 PubMed:18047674 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene EPHA2/NCBI:1969 199 BB1659-1 EPHA3 amplification EPHA3 NCBI:2042 gene cancer MONDO:0004992 PubMed:25125683 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene EPHA3/NCBI:2042 200 BB1660-1 ERBB2 oncogenic mutation ERBB2 NCBI:2064 gene non-small cell lung carcinoma (disease) MONDO:0005233 PubMed:25899785 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene ERBB2/NCBI:2064 201 check_entity BB1661-1 780GSP ERBB2 NCBI:2064 gene breast adenocarcinoma MONDO:0004988 PubMed:23220880 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition 780GSP [biomarker_term_in_review] 203 not_mapped BB1662-1 ERBB2 proximal exon 20 ERBB2 NCBI:2064 gene lung adenocarcinoma MONDO:0005061 PubMed:26598547 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition ERBB2 proximal exon 20 [biomarker_term_in_review] 204 not_mapped BB1665-1 ERBB2:D769Y ERBB2 NCBI:2064 gene Breast adenocarcinoma;Any cancer type MONDO:0004988 PubMed:23220880 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::D769Y sequence variation in gene ERBB2/NCBI:2064 207 check_entity BB1665-1 ERBB2:D769Y ERBB2 NCBI:2064 gene breast adenocarcinoma MONDO:0004988 PubMed:23220880 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::D769Y sequence variation in gene ERBB2/NCBI:2064 207 check_entity BB1666-1 ERBB2:G309E ERBB2 NCBI:2064 gene cancer MONDO:0004992 PubMed:22908275 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::G309E sequence variation in gene ERBB2/NCBI:2064 208 check_entity BB1667-1 ERBB2:G776L ERBB2 NCBI:2064 gene lung adenocarcinoma MONDO:0005061 PubMed:16775247 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::g776l sequence variation in gene ERBB2/NCBI:2064 209 check_entity BB1668-1 ERBB2:K753E ERBB2 NCBI:2064 gene breast adenocarcinoma MONDO:0004988 PubMed:27697991 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::K753E sequence variation in gene ERBB2/NCBI:2064 210 check_entity BB1669-1 ERBB2:L755S ERBB2 NCBI:2064 gene breast adenocarcinoma MONDO:0004988 PubMed:23220880 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::L755S sequence variation in gene ERBB2/NCBI:2064 211 check_entity BB1670-1 ERBB2:L869R ERBB2 NCBI:2064 gene breast adenocarcinoma MONDO:0004988 PubMed:28274957 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::L869R sequence variation in gene ERBB2/NCBI:2064 212 check_entity BB1672-1 ERBB2:T798I ERBB2 NCBI:2064 gene breast adenocarcinoma MONDO:0004988 PubMed:28274957 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::T798I sequence variation in gene ERBB2/NCBI:2064 214 check_entity BB1673-1 ERBB2:V659E ERBB2 NCBI:2064 gene Breast adenocarcinoma;Lung adenocarcinoma MONDO:0004988 PubMed:23950206 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V659E sequence variation in gene ERBB2/NCBI:2064 215 check_entity AN5048-21 ERBB2 amplification ERBB2 NCBI:2064 gene endometrial cancer MONDO:0011962 PubMed:26099744 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene ERBB2/NCBI:2064 217 AN5048-22 ERBB2 amplification ERBB2 NCBI:2064 gene lung adenocarcinoma MONDO:0005061 PubMed:27252416 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene ERBB2/NCBI:2064 218 AN5048-22 ERBB2 amplification ERBB2 NCBI:2064 gene lung adenocarcinoma MONDO:0005061 PubMed:22956644 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene ERBB2/NCBI:2064 218 AN5048-23 ERBB2 amplification ERBB2 NCBI:2064 gene colorectal adenocarcinoma MONDO:0005008 PubMed:22586653 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene ERBB2/NCBI:2064 219 AN5048-26 ERBB2 amplification ERBB2 NCBI:2064 gene childhood bladder carcinoma MONDO:0022578 PubMed:27044931 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene ERBB2/NCBI:2064 222 AN5048-25 ERBB2 amplification ERBB2 NCBI:2064 gene breast adenocarcinoma MONDO:0004988 PubMed:20142587 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene ERBB2/NCBI:2064 221 AN5048-27 ERBB2 amplification ERBB2 NCBI:2064 gene biliary tract neoplasm (disease) MONDO:0005304 PubMed:26022204 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene ERBB2/NCBI:2064 223 AN5048-24 ERBB2 amplification ERBB2 NCBI:2064 gene gastric carcinoma MONDO:0004950 PubMed:25694417 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene ERBB2/NCBI:2064 220 AN5048-24 ERBB2 amplification ERBB2 NCBI:2064 gene gastric carcinoma MONDO:0004950 PubMed:24960402 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene ERBB2/NCBI:2064 220 AN5048-28 ERBB2 amplification ERBB2 NCBI:2064 gene ovarian cancer MONDO:0008170 PubMed:20003286 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene ERBB2/NCBI:2064 224 AN5048-25 ERBB2 amplification ERBB2 NCBI:2064 gene breast adenocarcinoma MONDO:0004988 PubMed:21107682 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene ERBB2/NCBI:2064 221 AN5048-25 ERBB2 amplification ERBB2 NCBI:2064 gene breast adenocarcinoma MONDO:0004988 PubMed:21558407 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene ERBB2/NCBI:2064 221 AN5048-21 ERBB2 amplification ERBB2 NCBI:2064 gene endometrial cancer MONDO:0011962 PubMed:25294905 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene ERBB2/NCBI:2064 217 AN5048-25 ERBB2 amplification ERBB2 NCBI:2064 gene breast adenocarcinoma MONDO:0004988 PubMed:26977878 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene ERBB2/NCBI:2064 221 BB1674-1 ERBB2 expression + ESR1 overexpression ERBB2 NCBI:2064 gene breast adenocarcinoma MONDO:0004988 PubMed:26658964 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition ERBB2 expression + ESR1 overexpression [biomarker_term_in_review] 225 not_mapped BB1675-1 ERBB3:G284R ERBB3 NCBI:2065 gene childhood bladder carcinoma MONDO:0022578 PubMed:27044931 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::G284R sequence variation in gene ERBB3/NCBI:2065 229 check_entity BB1676-1 ERBB3:P262H ERBB3 NCBI:2065 gene cancer MONDO:0004992 PubMed:23680147 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::P262H sequence variation in gene ERBB3/NCBI:2065 230 check_entity BB1677-1 ERBB3 amplification ERBB3 NCBI:2065 gene colorectal adenocarcinoma MONDO:0005008 PubMed:25520391 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene ERBB3/NCBI:2065 231 BB1678-1 ERBB4:E317K ERBB4 NCBI:2066 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:19718025 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::E317K sequence variation in gene ERBB4/NCBI:2066 232 check_entity BB1679-1 ERBB4:H809G ERBB4 NCBI:2066 gene breast adenocarcinoma MONDO:0004988 PubMed:26530965 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::H809G sequence variation in gene ERBB4/NCBI:2066 233 check_entity BB1680-1 ERBB4 fusion ERBB4 NCBI:2066 gene lung adenocarcinoma MONDO:0005061 PubMed:24727320 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene ERBB4/NCBI:2066 234 check_entity BB1681-1 ERCC1 oncogenic mutation ERCC1 NCBI:2067 gene lung cancer MONDO:0008903 PubMed:23275151 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene ERCC1/NCBI:2067 235 check_entity BB1681-1 ERCC1 oncogenic mutation ERCC1 NCBI:2067 gene lung cancer MONDO:0008903 PubMed:23934192 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene ERCC1/NCBI:2067 235 check_entity BB1682-1 ERCC1 deletion ERCC1 NCBI:2067 gene lung cancer MONDO:0008903 PubMed:23275151 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene ERCC1/NCBI:2067 236 check_entity BB1682-1 ERCC1 deletion ERCC1 NCBI:2067 gene lung cancer MONDO:0008903 PubMed:23934192 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene ERCC1/NCBI:2067 236 check_entity BB1683-1 ERCC1 overexpression ERCC1 NCBI:2067 gene childhood bladder carcinoma MONDO:0022578 PubMed:20846399 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:expression Increased expression of gene ERCC1/NCBI:2067 237 BB1684-1 ERCC2 oncogenic mutation ERCC2 NCBI:2068 gene childhood bladder carcinoma MONDO:0022578 PubMed:25096233 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene ERCC2/NCBI:2068 238 check_entity BB1685-1 ERCC4 oncogenic mutation ERCC4 NCBI:2072 gene ovarian cancer MONDO:0008170 PubMed:25634215 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene ERCC4/NCBI:2072 239 check_entity BB1686-1 ERCC6 oncogenic mutation ERCC6 NCBI:2074 gene ovarian cancer MONDO:0008170 PubMed:25634215 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene ERCC6/NCBI:2074 240 check_entity BB1687-1 EREG amplification EREG NCBI:2069 gene colorectal adenocarcinoma MONDO:0005008 PubMed:19738126 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene EREG/NCBI:2069 241 BB1688-1 ESR1 oncogenic mutation ESR1 NCBI:2099 gene breast adenocarcinoma MONDO:0004988 PubMed:27269946 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene ESR1/NCBI:2099 242 check_entity BB1689-1 ESR1 (E380Q,537,538,L536,P535H) ESR1 NCBI:2099 gene breast adenocarcinoma MONDO:0004988 PubMed:24185512 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition ESR1 (E380Q,537,538,L536,P535H) [biomarker_term_in_review] 243 not_mapped BB1690-1 ESR1:Y537S ESR1 NCBI:2099 gene breast adenocarcinoma MONDO:0004988 PubMed:27986707 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::Y537S sequence variation in gene ESR1/NCBI:2099 244 check_entity BB1691-1 ESR1-YAP1 fusion ESR1 NCBI:2099 gene breast adenocarcinoma MONDO:0004988 PubMed:24055055 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::esr1-yap1:fusion sequence variation in gene ESR1/NCBI:2099 245 check_entity BB1692-1 EZH2 (Y641,A677) EZH2 NCBI:2146 gene lymphoma MONDO:0005062 PubMed:23023262 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition EZH2 (Y641,A677) [biomarker_term_in_review] 246 not_mapped BB1693-1 FANCA oncogenic mutation FANCA NCBI:2175 gene prostate adenocarcinoma MONDO:0005082 PubMed:26510020 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene FANCA/NCBI:2175 247 check_entity BB1694-1 FANCA deletion FANCA NCBI:2175 gene prostate adenocarcinoma MONDO:0005082 PubMed:26510020 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene FANCA/NCBI:2175 248 check_entity BB1695-1 FANCC oncogenic mutation FANCC NCBI:2176 gene childhood bladder carcinoma MONDO:0022578 PubMed:26238431 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene FANCC/NCBI:2176 249 check_entity BB1696-1 FANCC deletion FANCC NCBI:2176 gene childhood bladder carcinoma MONDO:0022578 PubMed:26238431 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene FANCC/NCBI:2176 250 check_entity BB1697-1 FBXW7 oncogenic mutation FBXW7 NCBI:55294 gene cancer MONDO:0004992 PubMed:21368834 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene FBXW7/NCBI:55294 251 check_entity BB1697-2 FBXW7 oncogenic mutation FBXW7 NCBI:55294 gene acute lymphoblastic leukemia (disease) MONDO:0004967 PubMed:20861909 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene FBXW7/NCBI:55294 252 check_entity BB1698-1 FBXW7 deletion FBXW7 NCBI:55294 gene cancer MONDO:0004992 PubMed:21368834 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene FBXW7/NCBI:55294 253 check_entity BB1698-2 FBXW7 deletion FBXW7 NCBI:55294 gene colorectal adenocarcinoma MONDO:0005008 PubMed:23558291 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene FBXW7/NCBI:55294 254 check_entity AN5132-2 FGF3 amplification FGF3 NCBI:2248 gene breast adenocarcinoma MONDO:0004988 PubMed:25193991 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene FGF3/NCBI:2248 255 AN5132-2 FGF3 amplification FGF3 NCBI:2248 gene breast adenocarcinoma MONDO:0004988 PubMed:23658459 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene FGF3/NCBI:2248 255 BB1699-1 FGF4 amplification FGF4 NCBI:2249 gene breast adenocarcinoma MONDO:0004988 PubMed:25193991 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene FGF4/NCBI:2249 256 BB1699-1 FGF4 amplification FGF4 NCBI:2249 gene breast adenocarcinoma MONDO:0004988 PubMed:23658459 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene FGF4/NCBI:2249 256 AN5133-10 FGFR1 amplification FGFR1 NCBI:2260 gene squamous cell lung carcinoma MONDO:0005097 PubMed:27870574 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene FGFR1/NCBI:2260 258 AN5133-11 FGFR1 amplification FGFR1 NCBI:2260 gene breast adenocarcinoma MONDO:0004988 PubMed:25193991 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene FGFR1/NCBI:2260 259 BB1700-1 A266 FGFR2 NCBI:2263 gene lung cancer MONDO:0008903 PubMed:26048680 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition A266 [biomarker_term_in_review] 260 not_mapped BB1701-1 FGFR2 (M536I,M538I,I548V,N550,E566G,L618M,K660E) FGFR2 NCBI:2263 gene endometrial cancer MONDO:0011962 PubMed:23908597 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition FGFR2 (M536I,M538I,I548V,N550,E566G,L618M,K660E) [biomarker_term_in_review] 261 not_mapped BB1702-1 FGFR2 (N549H,V564F,K659M,L617V,K641R,R565A) + FGFR2 fusion FGFR2 NCBI:2263 gene cholangiocarcinoma MONDO:0019087 PubMed:28034880 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::(n549h,v564f,k659m,l617v,k641r,r565a):+:fusion sequence variation in gene FGFR2/NCBI:2263 262 check_entity BB1703-1 FGFR2:S252W FGFR2 NCBI:2263 gene endometrial cancer MONDO:0011962 PubMed:18552176 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::S252W sequence variation in gene FGFR2/NCBI:2263 263 check_entity BB1705-1 FGFR2 (V565I,M536I,M538I,I548V,N550,E566G,L618M,K660E) FGFR2 NCBI:2263 gene endometrial cancer MONDO:0011962 PubMed:23908597 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition FGFR2 (V565I,M536I,M538I,I548V,N550,E566G,L618M,K660E) [biomarker_term_in_review] 265 not_mapped BB1706-1 FGFR2:W290C FGFR2 NCBI:2263 gene squamous cell lung carcinoma MONDO:0005097 PubMed:23786770 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::W290C sequence variation in gene FGFR2/NCBI:2263 266 check_entity AN5140-4 FGFR2 amplification FGFR2 NCBI:2263 gene breast adenocarcinoma MONDO:0004988 PubMed:25193991 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene FGFR2/NCBI:2263 267 BB1707-1 FGFR3 oncogenic mutation FGFR3 NCBI:2261 gene childhood bladder carcinoma MONDO:0022578 PubMed:27870574 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene FGFR3/NCBI:2261 271 check_entity BB1708-1 FGFR3 (K650) FGFR3 NCBI:2261 gene myeloid neoplasm MONDO:0005170 PubMed:19331127 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition FGFR3 (K650) [biomarker_term_in_review] 272 not_mapped BB1709-1 FGFR3 (K650,Y373C) FGFR3 NCBI:2261 gene myeloid neoplasm MONDO:0005170 PubMed:16091734 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition FGFR3 (K650,Y373C) [biomarker_term_in_review] 273 not_mapped BB1710-1 FGFR3:S249C FGFR3 NCBI:2261 gene lung adenocarcinoma MONDO:0005061 PubMed:27998968 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::S249C sequence variation in gene FGFR3/NCBI:2261 274 check_entity BB1711-1 FGFR3:V555M FGFR3 NCBI:2261 gene myeloid neoplasm MONDO:0005170 PubMed:22869148 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V555M sequence variation in gene FGFR3/NCBI:2261 275 check_entity BB1712-1 FGFR3:Y373C FGFR3 NCBI:2261 gene myeloid neoplasm MONDO:0005170 PubMed:19331127 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::Y373C sequence variation in gene FGFR3/NCBI:2261 276 check_entity AN5151-2 FGFR3 fusion FGFR3 NCBI:2261 gene childhood bladder carcinoma MONDO:0022578 PubMed:26324363 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene FGFR3/NCBI:2261 277 check_entity AN5151-3 FGFR3 fusion FGFR3 NCBI:2261 gene malignant glioma MONDO:0015917 PubMed:26324363 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene FGFR3/NCBI:2261 278 check_entity BB1713-1 FGFR3-TACC3 fusion FGFR3 NCBI:2261 gene non-small cell lung carcinoma (disease) MONDO:0005233 PubMed:25294908 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fgfr3-tacc3:fusion sequence variation in gene FGFR3/NCBI:2261 279 check_entity BB1714-1 FGFR4 (N535,V550) FGFR4 NCBI:2264 gene rhabdomyosarcoma (disease) MONDO:0005212 PubMed:19809159 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition FGFR4 (N535,V550) [biomarker_term_in_review] 280 not_mapped BB1715-1 FLCN deletion FLCN NCBI:201163 gene thyroid cancer MONDO:0002108 PubMed:25295501 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene FLCN/NCBI:201163 281 check_entity BB1716-1 FLT3-ITD FLT3 NCBI:2322 gene acute myeloid leukemia MONDO:0018874 PubMed:27520294 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition FLT3 ITD [biomarker_term_in_review] 282 not_mapped BB1716-1 FLT3-ITD FLT3 NCBI:2322 gene acute myeloid leukemia MONDO:0018874 PubMed:19389879 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition FLT3 ITD [biomarker_term_in_review] 282 not_mapped BB1716-1 FLT3-ITD FLT3 NCBI:2322 gene acute myeloid leukemia MONDO:0018874 PubMed:23613521 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition FLT3 ITD [biomarker_term_in_review] 282 not_mapped BB1716-1 FLT3-ITD FLT3 NCBI:2322 gene acute myeloid leukemia MONDO:0018874 PubMed:16857985 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition FLT3 ITD [biomarker_term_in_review] 282 not_mapped BB1717-1 FLT3 (D835) FLT3 NCBI:2322 gene acute myeloid leukemia MONDO:0018874 PubMed:16857985 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition FLT3 D835 [biomarker_term_in_review] 283 not_mapped BB1717-1 FLT3 (D835) FLT3 NCBI:2322 gene acute myeloid leukemia MONDO:0018874 PubMed:20733134 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition FLT3 D835 [biomarker_term_in_review] 283 not_mapped BB1718-1 FLT3 (D835,Y842) FLT3 NCBI:2322 gene acute myeloid leukemia MONDO:0018874 PubMed:23430109 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition FLT3 (D835,Y842) [biomarker_term_in_review] 284 not_mapped BB1719-1 FLT3 (F691) FLT3 NCBI:2322 gene acute myeloid leukemia MONDO:0018874 PubMed:25847190 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition FLT3 (F691) [biomarker_term_in_review] 285 not_mapped BB1720-1 FLT3 (F691,D835,N676,Y842) FLT3 NCBI:2322 gene acute myeloid leukemia MONDO:0018874 PubMed:22504184 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition FLT3 (F691,D835,N676,Y842) [biomarker_term_in_review] 286 not_mapped BB1721-1 FLT3 (N676) FLT3 NCBI:2322 gene acute myeloid leukemia MONDO:0018874 PubMed:24619500 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition FLT3 (N676) [biomarker_term_in_review] 287 not_mapped BB1722-1 FOXA1 amplification FOXA1 NCBI:3169 gene colorectal adenocarcinoma MONDO:0005008 PubMed:27397505 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene FOXA1/NCBI:3169 288 BB1723-1 FRS2 amplification FRS2 NCBI:10818 gene liposarcoma MONDO:0005060 PubMed:23393200 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene FRS2/NCBI:10818 289 BB1727-1 GATA3 oncogenic mutation GATA3 NCBI:2625 gene breast adenocarcinoma MONDO:0004988 PubMed:24758297 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene GATA3/NCBI:2625 293 check_entity BB1728-1 GLI2 amplification GLI2 NCBI:2736 gene medulloblastoma MONDO:0007959 PubMed:24951114 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene GLI2/NCBI:2736 294 BB1729-1 GNA11:Q209L GNA11 NCBI:2767 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:22733540 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::Q209L sequence variation in gene GNA11/NCBI:2767 295 check_entity BB1730-1 GNAQ (Q209) GNAQ NCBI:2776 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:22733540 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition GNAQ (Q209) [biomarker_term_in_review] 296 not_mapped BB1730-1 GNAQ (Q209) GNAQ NCBI:2776 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:22653968 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition GNAQ (Q209) [biomarker_term_in_review] 296 not_mapped BB1731-1 GNAS (R201) GNAS NCBI:2778 gene cancer MONDO:0004992 PubMed:21835143 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition GNAS (R201) [biomarker_term_in_review] 297 not_mapped BB1732-1 HDAC2 biallelic inactivation HDAC2 NCBI:3066 gene prostate adenocarcinoma MONDO:0005082 PubMed:26510020 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition HDAC2 biallelic inactivation [biomarker_term_in_review] 298 not_mapped BB1733-1 HGF amplification + ERBB2 amplification HGF NCBI:3082 gene breast adenocarcinoma MONDO:0004988 PubMed:22850551 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition HGF amplification + ERBB2 amplification [biomarker_term_in_review] 299 not_mapped BB1734-2 HRAS oncogenic mutation HRAS NCBI:3265 gene acute myeloid leukemia MONDO:0018874 PubMed:22399013 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene HRAS/NCBI:3265 301 check_entity BB1734-3 HRAS oncogenic mutation HRAS NCBI:3265 gene uterine cervix neoplasm MONDO:0021230 PubMed:15950068 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene HRAS/NCBI:3265 302 check_entity BB1735-2 IDH1 oncogenic mutation IDH1 NCBI:3417 gene acute myeloid leukemia MONDO:0018874 PubMed:27520294 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene IDH1/NCBI:3417 304 check_entity BB1735-2 IDH1 oncogenic mutation IDH1 NCBI:3417 gene acute myeloid leukemia MONDO:0018874 PubMed:25599133 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene IDH1/NCBI:3417 304 check_entity BB1736-1 IDH1 (R132) IDH1 NCBI:3417 gene biliary tract neoplasm (disease) MONDO:0005304 PubMed:27231123 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition IDH1 (R132) [biomarker_term_in_review] 306 not_mapped BB1736-2 IDH1 (R132) IDH1 NCBI:3417 gene cancer MONDO:0004992 PubMed:28148839 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition IDH1 (R132) [biomarker_term_in_review] 307 not_mapped BB1737-2 IDH2 oncogenic mutation IDH2 NCBI:3418 gene acute myeloid leukemia MONDO:0018874 PubMed:27520294 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene IDH2/NCBI:3418 309 check_entity BB1738-1 IDH2 (R172) IDH2 NCBI:3418 gene biliary tract neoplasm (disease) MONDO:0005304 PubMed:27231123 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition IDH2 (R172) [biomarker_term_in_review] 310 not_mapped BB1739-1 IGF1R amplification IGF1R NCBI:3480 gene lung adenocarcinoma MONDO:0005061 PubMed:24458568 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene IGF1R/NCBI:3480 311 BB1740-1 IGF2 amplification IGF2 NCBI:3481 gene colorectal adenocarcinoma MONDO:0005008 PubMed:25632036 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene IGF2/NCBI:3481 312 BB1741-1 237-255 IL7R NCBI:3575 gene acute lymphoblastic leukemia (disease) MONDO:0004967 PubMed:22897847 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition 237-255 [biomarker_term_in_review] 313 not_mapped BB1741-1 237-255 IL7R NCBI:3575 gene acute lymphoblastic leukemia (disease) MONDO:0004967 PubMed:22955920 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition 237-255 [biomarker_term_in_review] 313 not_mapped BB1742-1 IL7R (S185C) + SH2B3 deletion IL7R NCBI:3575 gene acute lymphoblastic leukemia (disease) MONDO:0004967 PubMed:22897847 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::(s185c):+:sh2b3:deletion sequence variation in gene IL7R/NCBI:3575 314 check_entity BB1742-1 IL7R (S185C) + SH2B3 deletion IL7R NCBI:3575 gene acute lymphoblastic leukemia (disease) MONDO:0004967 PubMed:22955920 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::(s185c):+:sh2b3:deletion sequence variation in gene IL7R/NCBI:3575 314 check_entity BB1743-1 INPP4B oncogenic mutation INPP4B NCBI:8821 gene breast adenocarcinoma MONDO:0004988 PubMed:23551093 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene INPP4B/NCBI:8821 315 check_entity BB1744-1 INPP4B deletion INPP4B NCBI:8821 gene breast adenocarcinoma MONDO:0004988 PubMed:23551093 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene INPP4B/NCBI:8821 316 check_entity BB1745-1 JAK1 oncogenic mutation JAK1 NCBI:3716 gene colorectal adenocarcinoma MONDO:0005008 PubMed:27903500 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene JAK1/NCBI:3716 317 check_entity BB1745-2 JAK1 oncogenic mutation JAK1 NCBI:3716 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:27433843 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene JAK1/NCBI:3716 318 check_entity BB1746-1 JAK1 (S646F;R683) JAK1 NCBI:3716 gene acute lymphoblastic leukemia (disease) MONDO:0004967 PubMed:22955920 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition JAK1 (S646F;R683) [biomarker_term_in_review] 319 not_mapped BB1747-1 JAK2 oncogenic mutation JAK2 NCBI:3717 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:27433843 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene JAK2/NCBI:3717 320 check_entity BB1748-1 JAK2:V617F JAK2 NCBI:3717 gene acute myeloid leukemia MONDO:0018874 PubMed:22422826 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V617F sequence variation in gene JAK2/NCBI:3717 321 check_entity BB1748-1 JAK2:V617F JAK2 NCBI:3717 gene acute myeloid leukemia MONDO:0018874 PubMed:22829971 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V617F sequence variation in gene JAK2/NCBI:3717 321 check_entity BB1749-1 JAK2 amplification JAK2 NCBI:3717 gene breast adenocarcinoma MONDO:0004988 PubMed:27075627 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene JAK2/NCBI:3717 323 BB1750-1 JAK2-BRAF fusion JAK2 NCBI:3717 gene acute lymphoblastic leukemia (disease) MONDO:0004967 PubMed:22875628 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::jak2-braf:fusion sequence variation in gene JAK2/NCBI:3717 324 check_entity BB1751-1 JAK3:A572V JAK3 NCBI:3718 gene lymphoma MONDO:0005062 PubMed:22705984 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::A572V sequence variation in gene JAK3/NCBI:3718 325 check_entity BB1752-1 KCNJ5:L168R KCNJ5 NCBI:3762 gene adrenal cortex adenoma MONDO:0003924 PubMed:24506072 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::L168R sequence variation in gene KCNJ5/NCBI:3762 326 check_entity BB1753-1 KDR:A1065T KDR NCBI:3791 gene cancer MONDO:0004992 PubMed:24569783 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::A1065T sequence variation in gene KDR/NCBI:3791 327 check_entity BB1755-1 KIT mutation in exon 11 KIT NCBI:3815 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:18955458 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::mutation:in:exon:11 sequence variation in gene KIT/NCBI:3815 329 check_entity BB1755-1 KIT mutation in exon 11 KIT NCBI:3815 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:22898035 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::mutation:in:exon:11 sequence variation in gene KIT/NCBI:3815 329 check_entity BB1756-1 KIT mutation in exon 9 or 11 KIT NCBI:3815 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:22270258 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::mutation:in:exon:9:or:11 sequence variation in gene KIT/NCBI:3815 330 check_entity BB1754-2 KIT mutation in exon 9,11,13,14 or 17 KIT NCBI:3815 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:19671763 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::mutation:in:exon:9,11,13,14:or:17 sequence variation in gene KIT/NCBI:3815 331 check_entity BB1754-2 KIT mutation in exon 9,11,13,14 or 17 KIT NCBI:3815 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:18421059 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::mutation:in:exon:9,11,13,14:or:17 sequence variation in gene KIT/NCBI:3815 331 check_entity BB1754-2 KIT mutation in exon 9,11,13,14 or 17 KIT NCBI:3815 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:22068222 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::mutation:in:exon:9,11,13,14:or:17 sequence variation in gene KIT/NCBI:3815 331 check_entity BB1757-1 KIT (550-592,627-664,788-828,829-860) KIT NCBI:3815 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:18936790 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition KIT (550-592,627-664,788-828,829-860) [biomarker_term_in_review] 332 not_mapped BB1758-1 KIT (627-664,664-714,449-514) KIT NCBI:3815 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:18955458 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition KIT (627-664,664-714,449-514) [biomarker_term_in_review] 333 not_mapped BB1759-1 KIT mutation in exon 17 KIT NCBI:3815 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:23840364 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::mutation:in:exon:17 sequence variation in gene KIT/NCBI:3815 334 check_entity BB1759-1 KIT mutation in exon 17 KIT NCBI:3815 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:22119758 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::mutation:in:exon:17 sequence variation in gene KIT/NCBI:3815 334 check_entity BB1760-1 KIT mutation in exon 9 or 17 KIT NCBI:3815 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:21737509 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::mutation:in:exon:9:or:17 sequence variation in gene KIT/NCBI:3815 335 check_entity BB1761-1 KIT mutation in exon 17 or 18 KIT NCBI:3815 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:21690468 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::mutation:in:exon:17:or:18 sequence variation in gene KIT/NCBI:3815 336 check_entity BB1763-1 416-422 KIT NCBI:3815 gene acute myeloid leukemia MONDO:0018874 PubMed:15618474 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition 416-422 [biomarker_term_in_review] 338 not_mapped AN5313-2 KIT wildtype KIT NCBI:3815 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:18955458 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition KIT wildtype [biomarker_term_in_review] 339 not_mapped AN5313-2 KIT wildtype KIT NCBI:3815 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:16397263 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition KIT wildtype [biomarker_term_in_review] 339 not_mapped BB1764-1 KIT:A829P KIT NCBI:3815 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:25239608 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::A829P sequence variation in gene KIT/NCBI:3815 340 check_entity BB1766-1 KIT:D816V KIT NCBI:3815 gene acute myeloid leukemia MONDO:0018874 PubMed:18986703 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::D816V sequence variation in gene KIT/NCBI:3815 342 check_entity BB1766-2 KIT:D816V KIT NCBI:3815 gene systemic mastocytosis MONDO:0016586 PubMed:18559612 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::D816V sequence variation in gene KIT/NCBI:3815 343 check_entity BB1767-1 KIT:D816Y KIT NCBI:3815 gene cancer MONDO:0004992 PubMed:16397263 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::D816Y sequence variation in gene KIT/NCBI:3815 344 check_entity BB1768-1 KIT:D820Y KIT NCBI:3815 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23775962 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::D820Y sequence variation in gene KIT/NCBI:3815 345 check_entity BB1768-1 KIT:D820Y KIT NCBI:3815 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:25695690 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::D820Y sequence variation in gene KIT/NCBI:3815 345 check_entity BB1769-1 KIT:N822K KIT NCBI:3815 gene acute myeloid leukemia MONDO:0018874 PubMed:23149070 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::N822K sequence variation in gene KIT/NCBI:3815 346 check_entity BB1770-1 KIT:T670I KIT NCBI:3815 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:24687822 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::T670I sequence variation in gene KIT/NCBI:3815 347 check_entity BB1771-1 KIT (V559I,H697Y,T670,V654A,A829P,D816,N822,Y823D) KIT NCBI:3815 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:23582185 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition KIT (V559I,H697Y,T670,V654A,A829P,D816,N822,Y823D) [biomarker_term_in_review] 348 not_mapped AN5272-2 KIT amplification KIT NCBI:3815 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23775962 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene KIT/NCBI:3815 349 AN5272-2 KIT amplification KIT NCBI:3815 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:22261812 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene KIT/NCBI:3815 349 BB1772-1 KRAS oncogenic mutation KRAS NCBI:3845 gene lung cancer MONDO:0008903 PubMed:26802155 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 350 check_entity BB1772-3 KRAS oncogenic mutation KRAS NCBI:3845 gene non-small cell lung carcinoma (disease) MONDO:0005233 PubMed:19238210 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 352 check_entity BB1772-5 KRAS oncogenic mutation KRAS NCBI:3845 gene gastric carcinoma MONDO:0004950 PubMed:22614881 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 354 check_entity BB1772-6 KRAS oncogenic mutation KRAS NCBI:3845 gene cancer MONDO:0004992 PubMed:26552009 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 355 check_entity BB1772-7 KRAS oncogenic mutation KRAS NCBI:3845 gene endometrial cancer MONDO:0011962 PubMed:22662154 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 356 check_entity BB1772-8 KRAS oncogenic mutation KRAS NCBI:3845 gene ovarian cancer MONDO:0008170 PubMed:25968887 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 357 check_entity BB1772-2 KRAS oncogenic mutation KRAS NCBI:3845 gene exocrine pancreatic carcinoma MONDO:0005192 PubMed:23583440 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 351 check_entity BB1772-9 KRAS oncogenic mutation KRAS NCBI:3845 gene lung adenocarcinoma MONDO:0005061 PubMed:27338794 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 358 check_entity BB1772-1 KRAS oncogenic mutation KRAS NCBI:3845 gene lung cancer MONDO:0008903 PubMed:23129625 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 350 check_entity BB1772-1 KRAS oncogenic mutation KRAS NCBI:3845 gene lung cancer MONDO:0008903 PubMed:20609353 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 350 check_entity BB1772-4 KRAS oncogenic mutation KRAS NCBI:3845 gene colorectal adenocarcinoma MONDO:0005008 PubMed:24553387 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 353 check_entity BB1772-4 KRAS oncogenic mutation KRAS NCBI:3845 gene colorectal adenocarcinoma MONDO:0005008 PubMed:23614898 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 353 check_entity BB1772-1 KRAS oncogenic mutation KRAS NCBI:3845 gene lung cancer MONDO:0008903 PubMed:23358651 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 350 check_entity BB1772-1 KRAS oncogenic mutation KRAS NCBI:3845 gene lung cancer MONDO:0008903 PubMed:23012248 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 350 check_entity BB1772-1 KRAS oncogenic mutation KRAS NCBI:3845 gene lung cancer MONDO:0008903 PubMed:24444711 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 350 check_entity BB1772-4 KRAS oncogenic mutation KRAS NCBI:3845 gene colorectal adenocarcinoma MONDO:0005008 PubMed:23245996 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 353 check_entity BB1772-4 KRAS oncogenic mutation KRAS NCBI:3845 gene colorectal adenocarcinoma MONDO:0005008 PubMed:24045180 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 353 check_entity BB1772-4 KRAS oncogenic mutation KRAS NCBI:3845 gene colorectal adenocarcinoma MONDO:0005008 PubMed:22392911 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 353 check_entity BB1772-1 KRAS oncogenic mutation KRAS NCBI:3845 gene Lung;Billiary tract MONDO:0008903 PubMed:23200175 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 350 check_entity BB1772-10 KRAS oncogenic mutation KRAS NCBI:3845 gene Acute myeloid leukemia;Cervix;Ovary MONDO:0018874 PubMed:22507781 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 359 check_entity BB1772-4 KRAS oncogenic mutation KRAS NCBI:3845 gene colorectal adenocarcinoma MONDO:0005008 PubMed:24163374 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 353 check_entity BB1772-1 KRAS oncogenic mutation KRAS NCBI:3845 gene lung cancer MONDO:0008903 PubMed:25516890 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 350 check_entity BB1772-7 KRAS oncogenic mutation KRAS NCBI:3845 gene endometrial cancer MONDO:0011962 PubMed:21984976 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 356 check_entity BB1772-1 KRAS oncogenic mutation KRAS NCBI:3845 gene lung cancer MONDO:0008903 PubMed:27217383 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene KRAS/NCBI:3845 350 check_entity BB1775-1 KRAS (G12) KRAS NCBI:3845 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:24687822 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition KRAS (G12) [biomarker_term_in_review] 362 not_mapped BB1775-2 KRAS (G12) KRAS NCBI:3845 gene acute lymphoblastic leukemia (disease) MONDO:0004967 PubMed:18701506 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition KRAS (G12) [biomarker_term_in_review] 363 not_mapped BB1776-1 KRAS:G13D KRAS NCBI:3845 gene colorectal adenocarcinoma MONDO:0005008 PubMed:27114605 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::G13D sequence variation in gene KRAS/NCBI:3845 364 check_entity BB1777-1 LRP1B oncogenic mutation LRP1B NCBI:53353 gene ovarian cancer MONDO:0008170 PubMed:22896685 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene LRP1B/NCBI:53353 366 check_entity AN5353-2 LRP1B deletion LRP1B NCBI:53353 gene ovarian cancer MONDO:0008170 PubMed:22896685 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene LRP1B/NCBI:53353 367 check_entity BB1778-1 MAP2K1 oncogenic mutation MAP2K1 NCBI:5604 gene colorectal adenocarcinoma MONDO:0005008 PubMed:26030179 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene MAP2K1/NCBI:5604 368 check_entity BB1779-1 MAP2K1 inframe deletion (56-60) MAP2K1 NCBI:5604 gene ovarian cancer MONDO:0008170 PubMed:26324360 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::inframe:deletion:(56-60) sequence variation in gene MAP2K1/NCBI:5604 369 check_entity BB1780-1 MAP2K1:C121S MAP2K1 NCBI:5604 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:24448821 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::C121S sequence variation in gene MAP2K1/NCBI:5604 370 check_entity BB1781-1 MAP2K1:E203K MAP2K1 NCBI:5604 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23569304 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::E203K sequence variation in gene MAP2K1/NCBI:5604 371 check_entity BB1782-1 MAP2K1 (F129L,L215P,I103N,P124) MAP2K1 NCBI:5604 gene cancer MONDO:0004992 PubMed:23614898 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition MAP2K1 (F129L,L215P,I103N,P124) [biomarker_term_in_review] 372 not_mapped BB1783-1 MAP2K1 (I99T,L115,G128D,F129L,V211D,L215P,I103N,K104N,I111N,H119P,E120D,F133L,P124,D67N) MAP2K1 NCBI:5604 gene cancer MONDO:0004992 PubMed:19915144 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition MAP2K1 (I99T,L115,G128D,F129L,V211D,L215P,I103N,K104N,I111N,H119P,E120D,F133L,P124,D67N) [biomarker_term_in_review] 373 not_mapped BB1784-1 MAP2K1:K57T MAP2K1 NCBI:5604 gene colorectal adenocarcinoma MONDO:0005008 PubMed:26644315 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::K57T sequence variation in gene MAP2K1/NCBI:5604 374 check_entity BB1785-1 MAP2K1 (P124) MAP2K1 NCBI:5604 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:25370473 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition MAP2K1 (P124) [biomarker_term_in_review] 375 not_mapped BB1786-1 MAP2K1:P124L MAP2K1 NCBI:5604 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:19915144 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::P124L sequence variation in gene MAP2K1/NCBI:5604 376 check_entity BB1787-1 MAP2K1 (P124S,I111S) + BRAF oncogenic mutation MAP2K1 NCBI:5604 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:22588879 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::(p124s,i111s):+:braf:oncogenic:mutation sequence variation in gene MAP2K1/NCBI:5604 377 check_entity BB1788-1 MAP2K1:Q56P MAP2K1 NCBI:5604 gene cancer MONDO:0004992 PubMed:26582713 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::Q56P sequence variation in gene MAP2K1/NCBI:5604 378 check_entity BB1788-2 MAP2K1:Q56P MAP2K1 NCBI:5604 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:19915144 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::Q56P sequence variation in gene MAP2K1/NCBI:5604 379 check_entity BB1789-1 MAP2K1 (Q56P,P124S,P124L;C121S) MAP2K1 NCBI:5604 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:19915144 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition MAP2K1 (Q56P,P124S,P124L;C121S) [biomarker_term_in_review] 380 not_mapped BB1790-1 MAP2K2:Q60P MAP2K2 NCBI:5605 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:24265154 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::Q60P sequence variation in gene MAP2K2/NCBI:5605 381 check_entity BB1791-1 MAP2K2:V35M MAP2K2 NCBI:5605 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:24265153 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V35M sequence variation in gene MAP2K2/NCBI:5605 382 check_entity BB1792-1 MCL1 amplification MCL1 NCBI:4170 gene cancer MONDO:0004992 PubMed:21368834 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene MCL1/NCBI:4170 383 BB1793-1 MDM2 amplification MDM2 NCBI:4193 gene liposarcoma MONDO:0005060 PubMed:23084521 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene MDM2/NCBI:4193 384 BB1794-1 MDM4 amplification MDM4 NCBI:4194 gene sarcoma MONDO:0005089 PubMed:24336067 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene MDM4/NCBI:4194 385 BB1795-1 MET:D1246V MET NCBI:4233 gene lung adenocarcinoma MONDO:0005061 PubMed:27694386 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::D1246V sequence variation in gene MET/NCBI:4233 386 check_entity BB1797-1 MET:V1110I MET NCBI:4233 gene cancer MONDO:0004992 PubMed:17483355 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V1110I sequence variation in gene MET/NCBI:4233 388 check_entity BB1798-1 MET (Y1230C;Y1235D) MET NCBI:4233 gene cancer MONDO:0004992 PubMed:17483355 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition MET (Y1230C;Y1235D) [biomarker_term_in_review] 389 not_mapped AN5370-8 MET amplification MET NCBI:4233 gene Non-small cell lung;Colorectal adenocarcinoma MONDO:0005233 PubMed:22189054 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene MET/NCBI:4233 390 AN5370-9 MET amplification MET NCBI:4233 gene lung adenocarcinoma MONDO:0005061 PubMed:27252416 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene MET/NCBI:4233 391 AN5370-10 MET amplification MET NCBI:4233 gene colorectal adenocarcinoma MONDO:0005008 PubMed:23729478 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene MET/NCBI:4233 392 AN5370-11 MET amplification MET NCBI:4233 gene malignant glioma MONDO:0015917 PubMed:22162573 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene MET/NCBI:4233 393 AN5370-10 MET amplification MET NCBI:4233 gene colorectal adenocarcinoma MONDO:0005008 PubMed:27397505 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene MET/NCBI:4233 392 AN5370-12 MET amplification MET NCBI:4233 gene gastric carcinoma MONDO:0004950 PubMed:22729845 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene MET/NCBI:4233 394 BB1799-1 MET amplification + BRAF (V600E) MET NCBI:4233 gene colorectal adenocarcinoma MONDO:0005008 PubMed:27325282 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition MET amplification + BRAF (V600E) [biomarker_term_in_review] 395 not_mapped BB1801-1 MET amplification + ERBB2 amplification MET NCBI:4233 gene gastric carcinoma MONDO:0004950 PubMed:22238368 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition MET amplification + ERBB2 amplification [biomarker_term_in_review] 397 not_mapped BB1801-2 MET amplification + ERBB2 amplification MET NCBI:4233 gene breast adenocarcinoma MONDO:0004988 PubMed:22850551 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition MET amplification + ERBB2 amplification [biomarker_term_in_review] 398 not_mapped BB1801-2 MET amplification + ERBB2 amplification MET NCBI:4233 gene Breast adenocarcinoma;Stomach MONDO:0004988 PubMed:22850551 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition MET amplification + ERBB2 amplification [biomarker_term_in_review] 398 not_mapped BB1801-1 MET amplification + ERBB2 amplification MET NCBI:4233 gene gastric carcinoma MONDO:0004950 PubMed:26432108 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition MET amplification + ERBB2 amplification [biomarker_term_in_review] 397 not_mapped BB1802-1 MET fusion MET NCBI:4233 gene malignant glioma MONDO:0015917 PubMed:27748748 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene MET/NCBI:4233 399 check_entity BB1803-1 MITF amplification MITF NCBI:4286 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:24265153 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene MITF/NCBI:4286 400 BB1806-1 MSH3 oncogenic mutation MSH3 NCBI:4437 gene cancer MONDO:0004992 PubMed:24556366 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene MSH3/NCBI:4437 401 check_entity BB1807-1 MTOR:E2014K MTOR NCBI:2475 gene childhood bladder carcinoma MONDO:0022578 PubMed:24625776 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::E2014K sequence variation in gene MTOR/NCBI:2475 402 check_entity BB1808-1 MTOR:F2108L MTOR NCBI:2475 gene cancer MONDO:0004992 PubMed:25295501 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::F2108L sequence variation in gene MTOR/NCBI:2475 403 check_entity BB1811-1 MTOR:L1460P MTOR NCBI:2475 gene cancer MONDO:0004992 PubMed:24631838 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::L1460P sequence variation in gene MTOR/NCBI:2475 406 check_entity BB1812-1 MTOR:N1421D MTOR NCBI:2475 gene gastric carcinoma MONDO:0004950 PubMed:26859683 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::N1421D sequence variation in gene MTOR/NCBI:2475 407 check_entity BB1813-1 MYC amplification MYC NCBI:4609 gene colorectal adenocarcinoma MONDO:0005008 PubMed:27397505 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene MYC/NCBI:4609 408 BB1813-2 MYC amplification MYC NCBI:4609 gene Myeloma;Neuroblastoma MONDO:0005170 PubMed:21889194 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene MYC/NCBI:4609 409 BB1813-3 MYC amplification MYC NCBI:4609 gene neuroblastoma MONDO:0005072 PubMed:25416950 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene MYC/NCBI:4609 410 BB1813-3 MYC amplification MYC NCBI:4609 gene neuroblastoma MONDO:0005072 PubMed:26537256 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene MYC/NCBI:4609 410 BB1813-4 MYC amplification MYC NCBI:4609 gene prostate adenocarcinoma MONDO:0005082 PubMed:25505253 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene MYC/NCBI:4609 411 AN5451-2 MYCN amplification MYCN NCBI:4613 gene medulloblastoma MONDO:0007959 PubMed:24951114 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene MYCN/NCBI:4613 412 BB1814-1 NF1 biallelic inactivation NF1 NCBI:4763 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23171796 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition NF1 biallelic inactivation [biomarker_term_in_review] 413 not_mapped BB1815-3 NF1 oncogenic mutation NF1 NCBI:4763 gene malignant glioma MONDO:0015917 PubMed:24634382 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 416 check_entity BB1815-1 NF1 oncogenic mutation NF1 NCBI:4763 gene plexiform neurofibroma (disease) MONDO:0003304 PubMed:24500418 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 414 check_entity BB1815-4 NF1 oncogenic mutation NF1 NCBI:4763 gene pediatric osteosarcoma MONDO:0002623 PubMed:26325560 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 417 check_entity BB1815-5 NF1 oncogenic mutation NF1 NCBI:4763 gene lung cancer MONDO:0008903 PubMed:24296828 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 418 check_entity BB1815-5 NF1 oncogenic mutation NF1 NCBI:4763 gene lung cancer MONDO:0008903 PubMed:24535670 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 418 check_entity BB1815-6 NF1 oncogenic mutation NF1 NCBI:4763 gene neuroblastoma MONDO:0005072 PubMed:20655465 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 419 check_entity BB1815-3 NF1 oncogenic mutation NF1 NCBI:4763 gene malignant glioma MONDO:0015917 PubMed:24232489 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 416 check_entity BB1815-1 NF1 oncogenic mutation NF1 NCBI:4763 gene plexiform neurofibroma (disease) MONDO:0003304 PubMed:23099009 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 414 check_entity BB1815-1 NF1 oncogenic mutation NF1 NCBI:4763 gene Plexiform neurofibroma;Malignant peripheral nerve sheat tumor MONDO:0003304 PubMed:24173684 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 414 check_entity BB1815-1 NF1 oncogenic mutation NF1 NCBI:4763 gene plexiform neurofibroma (disease) MONDO:0003304 PubMed:23099891 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 414 check_entity BB1815-1 NF1 oncogenic mutation NF1 NCBI:4763 gene plexiform neurofibroma (disease) MONDO:0003304 PubMed:25314964 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 414 check_entity BB1815-3 NF1 oncogenic mutation NF1 NCBI:4763 gene malignant glioma MONDO:0015917 PubMed:22434731 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 416 check_entity BB1815-2 NF1 oncogenic mutation NF1 NCBI:4763 gene malignant peripheral nerve sheath tumor MONDO:0017827 PubMed:25810463 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 415 check_entity BB1815-2 NF1 oncogenic mutation NF1 NCBI:4763 gene malignant peripheral nerve sheath tumor MONDO:0017827 PubMed:21075781 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 415 check_entity BB1815-3 NF1 oncogenic mutation NF1 NCBI:4763 gene malignant glioma MONDO:0015917 PubMed:26936308 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 416 check_entity BB1815-8 NF1 oncogenic mutation NF1 NCBI:4763 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:24576830 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 421 check_entity BB1815-2 NF1 oncogenic mutation NF1 NCBI:4763 gene malignant peripheral nerve sheath tumor MONDO:0017827 PubMed:24373973 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 415 check_entity BB1815-2 NF1 oncogenic mutation NF1 NCBI:4763 gene malignant peripheral nerve sheath tumor MONDO:0017827 PubMed:24718867 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 415 check_entity BB1815-3 NF1 oncogenic mutation NF1 NCBI:4763 gene Glioma;Leukemia MONDO:0015917 PubMed:22573716 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 416 check_entity BB1815-2 NF1 oncogenic mutation NF1 NCBI:4763 gene malignant peripheral nerve sheath tumor MONDO:0017827 PubMed:23221341 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 415 check_entity BB1815-2 NF1 oncogenic mutation NF1 NCBI:4763 gene malignant peripheral nerve sheath tumor MONDO:0017827 PubMed:21907929 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 415 check_entity BB1815-3 NF1 oncogenic mutation NF1 NCBI:4763 gene Glioma;Malignant peripheral nerve sheat tumor;Leukemia MONDO:0015917 PubMed:19573811 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 416 check_entity BB1815-8 NF1 oncogenic mutation NF1 NCBI:4763 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:26351322 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF1/NCBI:4763 421 check_entity BB1816-1 NF1 oncogenic mutation + BRAF oncogenic mutation NF1 NCBI:4763 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23444215 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation:+:braf:oncogenic:mutation sequence variation in gene NF1/NCBI:4763 422 check_entity BB1816-1 NF1 oncogenic mutation + BRAF oncogenic mutation NF1 NCBI:4763 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23288408 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation:+:braf:oncogenic:mutation sequence variation in gene NF1/NCBI:4763 422 check_entity BB1817-3 NF1 deletion NF1 NCBI:4763 gene malignant glioma MONDO:0015917 PubMed:24634382 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 425 check_entity BB1817-1 NF1 deletion NF1 NCBI:4763 gene plexiform neurofibroma (disease) MONDO:0003304 PubMed:24500418 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 423 check_entity BB1817-4 NF1 deletion NF1 NCBI:4763 gene pediatric osteosarcoma MONDO:0002623 PubMed:26325560 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 426 check_entity BB1817-5 NF1 deletion NF1 NCBI:4763 gene lung cancer MONDO:0008903 PubMed:24296828 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 427 check_entity BB1817-5 NF1 deletion NF1 NCBI:4763 gene lung cancer MONDO:0008903 PubMed:24535670 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 427 check_entity BB1817-6 NF1 deletion NF1 NCBI:4763 gene neuroblastoma MONDO:0005072 PubMed:20655465 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 428 check_entity BB1817-3 NF1 deletion NF1 NCBI:4763 gene malignant glioma MONDO:0015917 PubMed:24232489 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 425 check_entity BB1817-1 NF1 deletion NF1 NCBI:4763 gene plexiform neurofibroma (disease) MONDO:0003304 PubMed:23099009 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 423 check_entity BB1817-1 NF1 deletion NF1 NCBI:4763 gene Plexiform neurofibroma;Malignant peripheral nerve sheat tumor MONDO:0003304 PubMed:24173684 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 423 check_entity BB1817-1 NF1 deletion NF1 NCBI:4763 gene plexiform neurofibroma (disease) MONDO:0003304 PubMed:23099891 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 423 check_entity BB1817-1 NF1 deletion NF1 NCBI:4763 gene plexiform neurofibroma (disease) MONDO:0003304 PubMed:25314964 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 423 check_entity BB1817-3 NF1 deletion NF1 NCBI:4763 gene malignant glioma MONDO:0015917 PubMed:22434731 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 425 check_entity BB1817-2 NF1 deletion NF1 NCBI:4763 gene malignant peripheral nerve sheath tumor MONDO:0017827 PubMed:25810463 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 424 check_entity BB1817-2 NF1 deletion NF1 NCBI:4763 gene malignant peripheral nerve sheath tumor MONDO:0017827 PubMed:21075781 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 424 check_entity BB1817-3 NF1 deletion NF1 NCBI:4763 gene malignant glioma MONDO:0015917 PubMed:26936308 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 425 check_entity BB1817-7 NF1 deletion NF1 NCBI:4763 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:24576830 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 429 check_entity BB1817-2 NF1 deletion NF1 NCBI:4763 gene malignant peripheral nerve sheath tumor MONDO:0017827 PubMed:24373973 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 424 check_entity BB1817-2 NF1 deletion NF1 NCBI:4763 gene malignant peripheral nerve sheath tumor MONDO:0017827 PubMed:24718867 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 424 check_entity BB1817-3 NF1 deletion NF1 NCBI:4763 gene Glioma;Leukemia MONDO:0015917 PubMed:22573716 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 425 check_entity BB1817-2 NF1 deletion NF1 NCBI:4763 gene malignant peripheral nerve sheath tumor MONDO:0017827 PubMed:23221341 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 424 check_entity BB1817-2 NF1 deletion NF1 NCBI:4763 gene malignant peripheral nerve sheath tumor MONDO:0017827 PubMed:21907929 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 424 check_entity BB1817-3 NF1 deletion NF1 NCBI:4763 gene Glioma;Malignant peripheral nerve sheat tumor;Leukemia MONDO:0015917 PubMed:19573811 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 425 check_entity BB1817-7 NF1 deletion NF1 NCBI:4763 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:26351322 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF1/NCBI:4763 429 check_entity BB1818-1 NF1 deletion + BRAF oncogenic mutation NF1 NCBI:4763 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23444215 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion:+:braf:oncogenic:mutation sequence variation in gene NF1/NCBI:4763 430 check_entity BB1818-1 NF1 deletion + BRAF oncogenic mutation NF1 NCBI:4763 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23288408 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion:+:braf:oncogenic:mutation sequence variation in gene NF1/NCBI:4763 430 check_entity BB1819-1 NF2 oncogenic mutation NF2 NCBI:4771 gene schwannoma MONDO:0002546 PubMed:20736812 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF2/NCBI:4771 431 check_entity BB1819-1 NF2 oncogenic mutation NF2 NCBI:4771 gene schwannoma MONDO:0002546 PubMed:21778190 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF2/NCBI:4771 431 check_entity BB1819-1 NF2 oncogenic mutation NF2 NCBI:4771 gene schwannoma MONDO:0002546 PubMed:19587327 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF2/NCBI:4771 431 check_entity BB1819-1 NF2 oncogenic mutation NF2 NCBI:4771 gene schwannoma MONDO:0002546 PubMed:24311643 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF2/NCBI:4771 431 check_entity BB1819-2 NF2 oncogenic mutation NF2 NCBI:4771 gene pediatric meningioma MONDO:0003057 PubMed:26015296 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF2/NCBI:4771 432 check_entity BB1819-1 NF2 oncogenic mutation NF2 NCBI:4771 gene schwannoma MONDO:0002546 PubMed:19509233 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF2/NCBI:4771 431 check_entity BB1819-3 NF2 oncogenic mutation NF2 NCBI:4771 gene breast adenocarcinoma MONDO:0004988 PubMed:25878190 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF2/NCBI:4771 433 check_entity BB1819-4 NF2 oncogenic mutation NF2 NCBI:4771 gene Mesothelioma;Ovary MONDO:0002373 PubMed:24848258 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF2/NCBI:4771 434 check_entity BB1819-2 NF2 oncogenic mutation NF2 NCBI:4771 gene pediatric meningioma MONDO:0003057 PubMed:23714726 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF2/NCBI:4771 432 check_entity BB1819-5 NF2 oncogenic mutation NF2 NCBI:4771 gene thyroid cancer MONDO:0002108 PubMed:26359368 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF2/NCBI:4771 435 check_entity BB1819-2 NF2 oncogenic mutation NF2 NCBI:4771 gene pediatric meningioma MONDO:0003057 PubMed:19451225 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF2/NCBI:4771 432 check_entity BB1819-1 NF2 oncogenic mutation NF2 NCBI:4771 gene Schwannoma;Meningioma MONDO:0002546 PubMed:23960073 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF2/NCBI:4771 431 check_entity BB1819-1 NF2 oncogenic mutation NF2 NCBI:4771 gene schwannoma MONDO:0002546 PubMed:19359162 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF2/NCBI:4771 431 check_entity BB1819-1 NF2 oncogenic mutation NF2 NCBI:4771 gene Schwannoma;Neurofibroma MONDO:0002546 PubMed:22844108 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NF2/NCBI:4771 431 check_entity BB1820-1 NF2 oncogenic mutation + EGFR oncogenic mutation NF2 NCBI:4771 gene lung cancer MONDO:0008903 PubMed:24813888 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation:+:egfr:oncogenic:mutation sequence variation in gene NF2/NCBI:4771 436 check_entity BB1821-1 NF2 deletion NF2 NCBI:4771 gene schwannoma MONDO:0002546 PubMed:20736812 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF2/NCBI:4771 437 check_entity BB1821-1 NF2 deletion NF2 NCBI:4771 gene schwannoma MONDO:0002546 PubMed:21778190 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF2/NCBI:4771 437 check_entity BB1821-1 NF2 deletion NF2 NCBI:4771 gene schwannoma MONDO:0002546 PubMed:19587327 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF2/NCBI:4771 437 check_entity BB1821-1 NF2 deletion NF2 NCBI:4771 gene schwannoma MONDO:0002546 PubMed:24311643 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF2/NCBI:4771 437 check_entity BB1821-2 NF2 deletion NF2 NCBI:4771 gene pediatric meningioma MONDO:0003057 PubMed:26015296 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF2/NCBI:4771 438 check_entity BB1821-1 NF2 deletion NF2 NCBI:4771 gene schwannoma MONDO:0002546 PubMed:19509233 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF2/NCBI:4771 437 check_entity BB1821-3 NF2 deletion NF2 NCBI:4771 gene breast adenocarcinoma MONDO:0004988 PubMed:25878190 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF2/NCBI:4771 439 check_entity BB1821-4 NF2 deletion NF2 NCBI:4771 gene Mesothelioma;Ovary MONDO:0002373 PubMed:24848258 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF2/NCBI:4771 440 check_entity BB1821-2 NF2 deletion NF2 NCBI:4771 gene pediatric meningioma MONDO:0003057 PubMed:23714726 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF2/NCBI:4771 438 check_entity BB1821-5 NF2 deletion NF2 NCBI:4771 gene thyroid cancer MONDO:0002108 PubMed:26359368 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF2/NCBI:4771 441 check_entity BB1821-2 NF2 deletion NF2 NCBI:4771 gene pediatric meningioma MONDO:0003057 PubMed:19451225 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF2/NCBI:4771 438 check_entity BB1821-1 NF2 deletion NF2 NCBI:4771 gene Schwannoma;Meningioma MONDO:0002546 PubMed:23960073 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF2/NCBI:4771 437 check_entity BB1821-1 NF2 deletion NF2 NCBI:4771 gene schwannoma MONDO:0002546 PubMed:19359162 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF2/NCBI:4771 437 check_entity BB1821-1 NF2 deletion NF2 NCBI:4771 gene Schwannoma;Neurofibroma MONDO:0002546 PubMed:22844108 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene NF2/NCBI:4771 437 check_entity BB1822-1 NF2 deletion + EGFR oncogenic mutation NF2 NCBI:4771 gene lung cancer MONDO:0008903 PubMed:24813888 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion:+:egfr:oncogenic:mutation sequence variation in gene NF2/NCBI:4771 442 check_entity BB1823-1 NOTCH1 oncogenic mutation NOTCH1 NCBI:4851 gene mantle cell lymphoma MONDO:0018876 PubMed:22210878 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NOTCH1/NCBI:4851 443 check_entity BB1824-2 NOTCH1 activating mutation in Cterm-PEST domain NOTCH1 NCBI:4851 gene acute lymphoblastic leukemia (disease) MONDO:0004967 PubMed:19318552 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::activating:mutation:in:cterm-pest:domain sequence variation in gene NOTCH1/NCBI:4851 445 check_entity BB1824-2 NOTCH1 activating mutation in Cterm-PEST domain NOTCH1 NCBI:4851 gene acute lymphoblastic leukemia (disease) MONDO:0004967 PubMed:19246562 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::activating:mutation:in:cterm-pest:domain sequence variation in gene NOTCH1/NCBI:4851 445 check_entity BB1824-2 NOTCH1 activating mutation in Cterm-PEST domain NOTCH1 NCBI:4851 gene acute lymphoblastic leukemia (disease) MONDO:0004967 PubMed:15472075 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::activating:mutation:in:cterm-pest:domain sequence variation in gene NOTCH1/NCBI:4851 445 check_entity BB1824-3 NOTCH1 activating mutation in Cterm-PEST domain NOTCH1 NCBI:4851 gene breast adenocarcinoma MONDO:0004988 PubMed:25564152 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::activating:mutation:in:cterm-pest:domain sequence variation in gene NOTCH1/NCBI:4851 446 check_entity BB1825-1 NOTCH1 splice donor variant (2245-2536),splice acceptor variant (2245-2536),stop gained (2245-2536),stop lost (2245-2536),frameshift variant (2245-2536) NOTCH1 NCBI:4851 gene lung adenoid cystic carcinoma MONDO:0003181 PubMed:27870570 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition NOTCH1 splice donor variant (2245-2536),splice acceptor variant (2245-2536),stop gained (2245-2536),stop lost (2245-2536),frameshift variant (2245-2536) [biomarker_term_in_review] 447 not_mapped BB1826-1 NOTCH1 fusion NOTCH1 NCBI:4851 gene acute lymphoblastic leukemia (disease) MONDO:0004967 PubMed:16688224 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene NOTCH1/NCBI:4851 448 check_entity BB1826-2 NOTCH1 fusion NOTCH1 NCBI:4851 gene breast adenocarcinoma MONDO:0004988 PubMed:22101766 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene NOTCH1/NCBI:4851 449 check_entity BB1827-2 NOTCH2 activating mutation (missense in TAD or truncating in Cterm-PEST domain) NOTCH2 NCBI:4853 gene Breast adenocarcinoma;Acute myeloid leukemia;Acute lymphoblastic leukemia MONDO:0004988 PubMed:25564152 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::activating:mutation:(missense:in:tad:or:truncating:in:cterm-pest:domain) sequence variation in gene NOTCH2/NCBI:4853 451 check_entity BB1828-1 NOTCH2 fusion NOTCH2 NCBI:4853 gene breast adenocarcinoma MONDO:0004988 PubMed:22101766 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene NOTCH2/NCBI:4853 452 check_entity BB1829-1 NPM1 oncogenic mutation NPM1 NCBI:4869 gene acute myeloid leukemia MONDO:0018874 PubMed:22417203 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NPM1/NCBI:4869 453 check_entity BB1829-1 NPM1 oncogenic mutation NPM1 NCBI:4869 gene acute myeloid leukemia MONDO:0018874 PubMed:27535106 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NPM1/NCBI:4869 453 check_entity BB1830-1 NRAS oncogenic mutation NRAS NCBI:4893 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:20179705 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NRAS/NCBI:4893 454 check_entity BB1830-1 NRAS oncogenic mutation NRAS NCBI:4893 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:26658964 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NRAS/NCBI:4893 454 check_entity BB1830-1 NRAS oncogenic mutation NRAS NCBI:4893 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23538902 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NRAS/NCBI:4893 454 check_entity BB1830-2 NRAS oncogenic mutation NRAS NCBI:4893 gene colorectal adenocarcinoma MONDO:0005008 PubMed:23274911 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NRAS/NCBI:4893 455 check_entity BB1830-3 NRAS oncogenic mutation NRAS NCBI:4893 gene Acute myeloid leukemia;Lung adenocarcinoma;Acute lymphoblastic leukemia MONDO:0018874 PubMed:22507781 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NRAS/NCBI:4893 456 check_entity BB1830-4 NRAS oncogenic mutation NRAS NCBI:4893 gene myeloid neoplasm MONDO:0005170 PubMed:22985491 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene NRAS/NCBI:4893 457 check_entity BB1831-1 NRAS (12,13,59,61,117,146) NRAS NCBI:4893 gene colorectal adenocarcinoma MONDO:0005008 PubMed:24024839 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition NRAS (12,13,59,61,117,146) [biomarker_term_in_review] 458 not_mapped BB1832-1 NRAS:G12C NRAS NCBI:4893 gene cancer MONDO:0004992 PubMed:23614898 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::G12C sequence variation in gene NRAS/NCBI:4893 459 check_entity BB1833-1 NRAS (Q61) NRAS NCBI:4893 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23569304 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition NRAS Q61 [biomarker_term_in_review] 460 not_mapped BB1833-1 NRAS (Q61) NRAS NCBI:4893 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23414587,ASCO 2016 (abstr 9500) assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition NRAS Q61 [biomarker_term_in_review] 460 not_mapped AN5497-3 NRG1 fusion NRG1 NCBI:3084 gene lung adenocarcinoma MONDO:0005061 PubMed:24727320 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene NRG1/NCBI:3084 461 check_entity BB1834-1 NTRK1:G595R NTRK1 NCBI:4914 gene cancer MONDO:0004992 PubMed:28578312 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::G595R sequence variation in gene NTRK1/NCBI:4914 462 check_entity BB1834-2 NTRK1:G595R NTRK1 NCBI:4914 gene colorectal adenocarcinoma MONDO:0005008 PubMed:26546295 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::G595R sequence variation in gene NTRK1/NCBI:4914 463 check_entity AN5510-6 NTRK1 fusion NTRK1 NCBI:4914 gene colorectal adenocarcinoma MONDO:0005008 PubMed:26546295 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene NTRK1/NCBI:4914 465 check_entity AN5510-5 NTRK1 fusion NTRK1 NCBI:4914 gene lung adenocarcinoma MONDO:0005061 PubMed:24162815 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene NTRK1/NCBI:4914 464 check_entity AN5510-7 NTRK1 fusion NTRK1 NCBI:4914 gene cancer MONDO:0004992 PubMed:28183697 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene NTRK1/NCBI:4914 466 check_entity BB1835-1 NTRK3:G623R NTRK3 NCBI:4916 gene cancer MONDO:0004992 PubMed:28578312 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::G623R sequence variation in gene NTRK3/NCBI:4916 467 check_entity AN5535-2 NTRK3 fusion NTRK3 NCBI:4916 gene breast adenocarcinoma MONDO:0004988 PubMed:21148487 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene NTRK3/NCBI:4916 468 check_entity BB1836-1 PAK1 amplification PAK1 NCBI:5058 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23535073 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene PAK1/NCBI:5058 469 BB1837-1 PALB2 oncogenic mutation PALB2 NCBI:79728 gene exocrine pancreatic carcinoma MONDO:0005192 PubMed:21135251 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PALB2/NCBI:79728 470 check_entity BB1837-1 PALB2 oncogenic mutation PALB2 NCBI:79728 gene exocrine pancreatic carcinoma MONDO:0005192 PubMed:25719666 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PALB2/NCBI:79728 470 check_entity BB1837-1 PALB2 oncogenic mutation PALB2 NCBI:79728 gene exocrine pancreatic carcinoma MONDO:0005192 PubMed:25263539 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PALB2/NCBI:79728 470 check_entity BB1838-1 PALB2 deletion PALB2 NCBI:79728 gene exocrine pancreatic carcinoma MONDO:0005192 PubMed:21135251 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene PALB2/NCBI:79728 472 check_entity BB1838-1 PALB2 deletion PALB2 NCBI:79728 gene exocrine pancreatic carcinoma MONDO:0005192 PubMed:25719666 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene PALB2/NCBI:79728 472 check_entity BB1838-1 PALB2 deletion PALB2 NCBI:79728 gene exocrine pancreatic carcinoma MONDO:0005192 PubMed:25263539 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene PALB2/NCBI:79728 472 check_entity BB1839-1 PBRM1 oncogenic mutation PBRM1 NCBI:55193 gene cancer MONDO:0004992 PubMed:26552009 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PBRM1/NCBI:55193 474 check_entity BB1840-1 PBRM1 deletion PBRM1 NCBI:55193 gene cancer MONDO:0004992 PubMed:26552009 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene PBRM1/NCBI:55193 475 check_entity BB1844-1 PDGFRA wildtype PDGFRA NCBI:5156 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:14645423 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition PDGFRA wildtype [biomarker_term_in_review] 479 not_mapped BB1844-1 PDGFRA wildtype PDGFRA NCBI:5156 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:16397263 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition PDGFRA wildtype [biomarker_term_in_review] 479 not_mapped BB1844-1 PDGFRA wildtype PDGFRA NCBI:5156 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:18955458 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition PDGFRA wildtype [biomarker_term_in_review] 479 not_mapped BB1845-1 PDGFRA:D842V PDGFRA NCBI:5156 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:22718859 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::D842V sequence variation in gene PDGFRA/NCBI:5156 480 check_entity BB1845-1 PDGFRA:D842V PDGFRA NCBI:5156 gene gastrointestinal stromal tumor MONDO:0011719 PubMed:18794084 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::D842V sequence variation in gene PDGFRA/NCBI:5156 480 check_entity BB1846-1 PDGFRA:P577S PDGFRA NCBI:5156 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:24132921 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::P577S sequence variation in gene PDGFRA/NCBI:5156 481 check_entity BB1847-1 PDGFRA:V658A PDGFRA NCBI:5156 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:24132921 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::V658A sequence variation in gene PDGFRA/NCBI:5156 482 check_entity AN5551-2 PDGFRA amplification PDGFRA NCBI:5156 gene malignant glioma MONDO:0015917 PubMed:23544171 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene PDGFRA/NCBI:5156 483 BB1848-1 PDPK1 amplification PDPK1 NCBI:5170 gene breast adenocarcinoma MONDO:0004988 PubMed:19602588 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene PDPK1/NCBI:5170 484 BB1849-2 PIK3CA oncogenic mutation PIK3CA NCBI:5290 gene colorectal adenocarcinoma MONDO:0005008 PubMed:19223544 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PIK3CA/NCBI:5290 486 check_entity BB1849-1 PIK3CA oncogenic mutation PIK3CA NCBI:5290 gene Lung;Colorectal adenocarcinoma MONDO:0008903 PubMed:23136191 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PIK3CA/NCBI:5290 485 check_entity BB1849-3 PIK3CA oncogenic mutation PIK3CA NCBI:5290 gene Breast adenocarcinoma;Ovary;Cervix squamous cell;Endometrium MONDO:0004988 PubMed:22271473 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PIK3CA/NCBI:5290 487 check_entity BB1849-5 PIK3CA oncogenic mutation PIK3CA NCBI:5290 gene Glioma;Thyroid carcinoma MONDO:0015917 PubMed:19671762 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PIK3CA/NCBI:5290 489 check_entity BB1849-3 PIK3CA oncogenic mutation PIK3CA NCBI:5290 gene breast adenocarcinoma MONDO:0004988 PubMed:28331003 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PIK3CA/NCBI:5290 487 check_entity BB1850-1 PIK3CA oncogenic mutation + ERBB2 amplification PIK3CA NCBI:5290 gene breast adenocarcinoma MONDO:0004988 PubMed:27091708 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation:+:erbb2:amplification sequence variation in gene PIK3CA/NCBI:5290 491 check_entity AN5576-7 PIK3CA amplification PIK3CA NCBI:5290 gene breast adenocarcinoma MONDO:0004988 PubMed:24366379 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene PIK3CA/NCBI:5290 493 BB1852-1 PIK3CB:D1067Y PIK3CB NCBI:5291 gene breast adenocarcinoma MONDO:0004988 PubMed:26759240 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::D1067Y sequence variation in gene PIK3CB/NCBI:5291 494 check_entity BB1853-1 PIK3R1 oncogenic mutation PIK3R1 NCBI:5295 gene malignant glioma MONDO:0015917 PubMed:23166678 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PIK3R1/NCBI:5295 495 check_entity BB1854-1 PIK3R2:A171V PIK3R2 NCBI:5296 gene endometrial cancer MONDO:0011962 PubMed:21984976 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::A171V sequence variation in gene PIK3R2/NCBI:5296 497 check_entity BB1855-1 PLCG2:R665W PLCG2 NCBI:5336 gene B-cell chronic lymphocytic leukemia MONDO:0004948 PubMed:24869598 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::R665W sequence variation in gene PLCG2/NCBI:5336 498 check_entity BB1857-1 POLE oncogenic mutation POLE NCBI:5426 gene colorectal adenocarcinoma MONDO:0005008 PubMed:28188185 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene POLE/NCBI:5426 501 check_entity BB1858-1 POLE (268-471) POLE NCBI:5426 gene Glioma;Endometrium MONDO:0015917 PubMed:27001570 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition POLE (268-471) [biomarker_term_in_review] 502 not_mapped BB1859-1 PRKCH amplification + ABL1-BCR fusion PRKCH NCBI:5583 gene chronic myelogenous leukemia, BCR-ABL1 positive MONDO:0011996 PubMed:25186176 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::amplification:+:abl1-bcr:fusion sequence variation in gene PRKCH/NCBI:5583 503 check_entity BB1860-1 PTCH1 oncogenic mutation PTCH1 NCBI:5727 gene medulloblastoma MONDO:0007959 PubMed:24651015 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PTCH1/NCBI:5727 504 check_entity BB1860-1 PTCH1 oncogenic mutation PTCH1 NCBI:5727 gene medulloblastoma MONDO:0007959 PubMed:25391241 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PTCH1/NCBI:5727 504 check_entity BB1860-2 PTCH1 oncogenic mutation PTCH1 NCBI:5727 gene Basal cell carcinoma;Medulloblastoma MONDO:0005341 PubMed:19726763 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PTCH1/NCBI:5727 505 check_entity BB1861-1 PTEN biallelic inactivation PTEN NCBI:5728 gene breast adenocarcinoma MONDO:0004988 PubMed:25409150 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition PTEN biallelic inactivation [biomarker_term_in_review] 506 not_mapped BB1862-1 PTEN oncogenic mutation PTEN NCBI:5728 gene endometrial cancer MONDO:0011962 PubMed:21788564 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PTEN/NCBI:5728 508 check_entity BB1862-2 PTEN oncogenic mutation PTEN NCBI:5728 gene colorectal adenocarcinoma MONDO:0005008 PubMed:21163703 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PTEN/NCBI:5728 509 check_entity BB1862-3 PTEN oncogenic mutation PTEN NCBI:5728 gene prostate adenocarcinoma MONDO:0005082 PubMed:23582881 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PTEN/NCBI:5728 510 check_entity BB1862-5 PTEN oncogenic mutation PTEN NCBI:5728 gene exocrine pancreatic carcinoma MONDO:0005192 PubMed:22025163 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PTEN/NCBI:5728 512 check_entity BB1862-6 PTEN oncogenic mutation PTEN NCBI:5728 gene breast adenocarcinoma MONDO:0004988 PubMed:27397505 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PTEN/NCBI:5728 513 check_entity BB1862-1 PTEN oncogenic mutation PTEN NCBI:5728 gene endometrial cancer MONDO:0011962 PubMed:21468130 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PTEN/NCBI:5728 508 check_entity BB1862-7 PTEN oncogenic mutation PTEN NCBI:5728 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:26645196 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PTEN/NCBI:5728 514 check_entity BB1862-3 PTEN oncogenic mutation PTEN NCBI:5728 gene prostate adenocarcinoma MONDO:0005082 PubMed:21575859 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PTEN/NCBI:5728 510 check_entity BB1862-8 PTEN oncogenic mutation PTEN NCBI:5728 gene ovarian cancer MONDO:0008170 PubMed:21632463 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PTEN/NCBI:5728 515 check_entity BB1862-9 PTEN oncogenic mutation PTEN NCBI:5728 gene Thyroid;Glioma;Lung;Ovary;Breast adenocarcinoma;Any cancer type;Endometrium MONDO:0002108 PubMed:21289267 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PTEN/NCBI:5728 516 check_entity BB1863-1 PTEN oncogenic mutation + BRAF oncogenic mutation PTEN NCBI:5728 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23039341 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation:+:braf:oncogenic:mutation sequence variation in gene PTEN/NCBI:5728 517 check_entity BB1864-1 PTEN oncogenic mutation + ERBB2 amplification PTEN NCBI:5728 gene breast adenocarcinoma MONDO:0004988 PubMed:27091708 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation:+:erbb2:amplification sequence variation in gene PTEN/NCBI:5728 518 check_entity AN5659-3 PTEN deletion PTEN NCBI:5728 gene endometrial cancer MONDO:0011962 PubMed:21788564 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene PTEN/NCBI:5728 519 check_entity AN5659-4 PTEN deletion PTEN NCBI:5728 gene colorectal adenocarcinoma MONDO:0005008 PubMed:21163703 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene PTEN/NCBI:5728 520 check_entity AN5659-5 PTEN deletion PTEN NCBI:5728 gene prostate adenocarcinoma MONDO:0005082 PubMed:23582881 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene PTEN/NCBI:5728 521 check_entity AN5659-7 PTEN deletion PTEN NCBI:5728 gene exocrine pancreatic carcinoma MONDO:0005192 PubMed:22025163 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene PTEN/NCBI:5728 523 check_entity AN5659-3 PTEN deletion PTEN NCBI:5728 gene endometrial cancer MONDO:0011962 PubMed:21468130 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene PTEN/NCBI:5728 519 check_entity AN5659-8 PTEN deletion PTEN NCBI:5728 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:26645196 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene PTEN/NCBI:5728 524 check_entity AN5659-5 PTEN deletion PTEN NCBI:5728 gene prostate adenocarcinoma MONDO:0005082 PubMed:21575859 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene PTEN/NCBI:5728 521 check_entity AN5659-9 PTEN deletion PTEN NCBI:5728 gene ovarian cancer MONDO:0008170 PubMed:21632463 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene PTEN/NCBI:5728 525 check_entity AN5659-10 PTEN deletion PTEN NCBI:5728 gene Thyroid;Glioma;Lung;Ovary;Breast adenocarcinoma;Any cancer type;Endometrium MONDO:0002108 PubMed:21289267 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene PTEN/NCBI:5728 526 check_entity BB1865-1 PTEN deletion + BRAF oncogenic mutation PTEN NCBI:5728 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23039341 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion:+:braf:oncogenic:mutation sequence variation in gene PTEN/NCBI:5728 527 check_entity BB1866-1 PTPRD oncogenic mutation PTPRD NCBI:5789 gene sarcoma MONDO:0005089 PubMed:23800680 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene PTPRD/NCBI:5789 528 check_entity BB1867-1 RAC1 (P29S) + BRAF oncogenic mutation RAC1 NCBI:5879 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:25056119 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::(p29s):+:braf:oncogenic:mutation sequence variation in gene RAC1/NCBI:5879 529 check_entity BB1868-1 RAD50 (L1237F) + ATM deletion RAD50 NCBI:10111 gene cancer MONDO:0004992 PubMed:24934408 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::(l1237f):+:atm:deletion sequence variation in gene RAD50/NCBI:10111 530 check_entity BB1870-1 RAF1 (S257P,G361A,P261P) + BRAF oncogenic mutation RAF1 NCBI:5894 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:23737487 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::(s257p,g361a,p261p):+:braf:oncogenic:mutation sequence variation in gene RAF1/NCBI:5894 532 check_entity BB1871-1 RAF1 overexpression RAF1 NCBI:5894 gene pediatric osteosarcoma MONDO:0002623 PubMed:24375110 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:expression Increased expression of gene RAF1/NCBI:5894 533 BB1872-1 RAF1 fusion RAF1 NCBI:5894 gene prostate adenocarcinoma MONDO:0005082 PubMed:20526349 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene RAF1/NCBI:5894 534 check_entity BB1873-1 RB1 oncogenic mutation RB1 NCBI:5925 gene childhood bladder carcinoma MONDO:0022578 PubMed:26238431 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene RB1/NCBI:5925 535 check_entity BB1873-2 RB1 oncogenic mutation RB1 NCBI:5925 gene retinoblastoma MONDO:0008380 PubMed:18483379 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene RB1/NCBI:5925 536 check_entity BB1873-2 RB1 oncogenic mutation RB1 NCBI:5925 gene retinoblastoma MONDO:0008380 PubMed:17080083 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene RB1/NCBI:5925 536 check_entity BB1874-1 RB1 deletion RB1 NCBI:5925 gene childhood bladder carcinoma MONDO:0022578 PubMed:26238431 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene RB1/NCBI:5925 537 check_entity BB1874-2 RB1 deletion RB1 NCBI:5925 gene retinoblastoma MONDO:0008380 PubMed:18483379 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene RB1/NCBI:5925 538 check_entity BB1874-2 RB1 deletion RB1 NCBI:5925 gene retinoblastoma MONDO:0008380 PubMed:17080083 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene RB1/NCBI:5925 538 check_entity AN5688-2 RB1 overexpression RB1 NCBI:5925 gene prostate adenocarcinoma MONDO:0005082 PubMed:23708653 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:expression Increased expression of gene RB1/NCBI:5925 539 BB1875-1 RET:C634W RET NCBI:5979 gene thyroid cancer MONDO:0002108 PubMed:21470995 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::C634W sequence variation in gene RET/NCBI:5979 540 check_entity BB1875-1 RET:C634W RET NCBI:5979 gene thyroid cancer MONDO:0002108 PubMed:23056499 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::C634W sequence variation in gene RET/NCBI:5979 540 check_entity BB1876-1 RET:I788N RET NCBI:5979 gene lung adenocarcinoma MONDO:0005061 PubMed:28615362 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::I788N sequence variation in gene RET/NCBI:5979 541 check_entity AN5695-5 RET fusion RET NCBI:5979 gene lung adenocarcinoma MONDO:0005061 PubMed:28447912 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene RET/NCBI:5979 542 check_entity AN5695-5 RET fusion RET NCBI:5979 gene lung adenocarcinoma MONDO:0005061 PubMed:26787234 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene RET/NCBI:5979 542 check_entity AN5695-5 RET fusion RET NCBI:5979 gene lung adenocarcinoma MONDO:0005061 PubMed:22327624 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene RET/NCBI:5979 542 check_entity BB1877-1 RET-TPCN1 fusion RET NCBI:5979 gene thyroid cancer MONDO:0002108 PubMed:23056499 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::ret-tpcn1:fusion sequence variation in gene RET/NCBI:5979 543 check_entity AN5702-3 RICTOR amplification RICTOR NCBI:253260 gene lung cancer MONDO:0008903 PubMed:26370156 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene RICTOR/NCBI:253260 544 BB1879-1 ROS1:G2032R ROS1 NCBI:6098 gene lung adenocarcinoma MONDO:0005061 PubMed:23724914 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::g2032r sequence variation in gene ROS1/NCBI:6098 546 check_entity BB1879-1 ROS1:G2032R ROS1 NCBI:6098 gene lung adenocarcinoma MONDO:0005061 PubMed:25351743 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::g2032r sequence variation in gene ROS1/NCBI:6098 546 check_entity BB1880-1 ROS1:S1986Y ROS1 NCBI:6098 gene lung adenocarcinoma MONDO:0005061 PubMed:27401242 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::S1986Y sequence variation in gene ROS1/NCBI:6098 547 check_entity AN5710-3 ROS1 fusion ROS1 NCBI:6098 gene lung adenocarcinoma MONDO:0005061 PubMed:27370605 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene ROS1/NCBI:6098 549 check_entity AN5710-3 ROS1 fusion ROS1 NCBI:6098 gene lung adenocarcinoma MONDO:0005061 PubMed:25264305 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene ROS1/NCBI:6098 549 check_entity AN5710-3 ROS1 fusion ROS1 NCBI:6098 gene lung adenocarcinoma MONDO:0005061 PubMed:23533265 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene ROS1/NCBI:6098 549 check_entity BB1881-1 SERPINB3 oncogenic mutation SERPINB3 NCBI:6317 gene cutaneous melanoma (disease) MONDO:0005012 PubMed:27668655 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene SERPINB3/NCBI:6317 550 check_entity BB1885-1 SLC29A1 oncogenic mutation SLC29A1 NCBI:2030 gene childhood bladder carcinoma MONDO:0022578 PubMed:21166756 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene SLC29A1/NCBI:2030 554 check_entity BB1886-1 SLC44A4 overexpression SLC44A4 NCBI:80736 gene Prostate adenocarcinoma;Pancreas adenocarcinoma MONDO:0005082 PubMed:27550944 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:expression Increased expression of gene SLC44A4/NCBI:80736 555 BB1887-1 SMARCA1 oncogenic mutation SMARCA1 NCBI:6594 gene cancer MONDO:0004992 PubMed:26552009 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene SMARCA1/NCBI:6594 556 check_entity BB1890-1 SMARCB1 oncogenic mutation SMARCB1 NCBI:6598 gene rhabdoid tumor MONDO:0002728 PubMed:26920892 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene SMARCB1/NCBI:6598 559 check_entity BB1891-1 SMO:D473H SMO NCBI:6608 gene medulloblastoma MONDO:0007959 PubMed:19726788 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::D473H sequence variation in gene SMO/NCBI:6608 561 check_entity BB1891-2 SMO:D473H SMO NCBI:6608 gene skin basal cell carcinoma MONDO:0005341 PubMed:25759020 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::D473H sequence variation in gene SMO/NCBI:6608 562 check_entity BB1893-1 SRSF2 oncogenic mutation SRSF2 NCBI:6427 gene acute myeloid leukemia MONDO:0018874 PubMed:27135740 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene SRSF2/NCBI:6427 564 check_entity BB1894-1 STAG2 oncogenic mutation STAG2 NCBI:10735 gene malignant glioma MONDO:0015917 PubMed:24356817 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene STAG2/NCBI:10735 565 check_entity BB1895-1 STK11 oncogenic mutation STK11 NCBI:6794 gene lung cancer MONDO:0008903 PubMed:23129625 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene STK11/NCBI:6794 566 check_entity BB1895-2 STK11 oncogenic mutation STK11 NCBI:6794 gene lung adenocarcinoma MONDO:0005061 PubMed:23352126 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene STK11/NCBI:6794 567 check_entity BB1895-2 STK11 oncogenic mutation STK11 NCBI:6794 gene lung adenocarcinoma MONDO:0005061 PubMed:19165201 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene STK11/NCBI:6794 567 check_entity BB1895-3 STK11 oncogenic mutation STK11 NCBI:6794 gene cancer MONDO:0004992 PubMed:19541609 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene STK11/NCBI:6794 568 check_entity BB1895-2 STK11 oncogenic mutation STK11 NCBI:6794 gene lung adenocarcinoma MONDO:0005061 PubMed:20541700 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene STK11/NCBI:6794 567 check_entity BB1896-1 STK11 oncogenic mutation + KRAS oncogenic mutation STK11 NCBI:6794 gene lung adenocarcinoma MONDO:0005061 PubMed:22425996 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation:+:kras:oncogenic:mutation sequence variation in gene STK11/NCBI:6794 569 check_entity BB1897-1 STK11:D194E STK11 NCBI:6794 gene exocrine pancreatic carcinoma MONDO:0005192 PubMed:21189378 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::d194e sequence variation in gene STK11/NCBI:6794 570 check_entity BB1898-1 STK11 deletion STK11 NCBI:6794 gene lung adenocarcinoma MONDO:0005061 PubMed:23352126 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene STK11/NCBI:6794 571 check_entity BB1898-1 STK11 deletion STK11 NCBI:6794 gene lung adenocarcinoma MONDO:0005061 PubMed:19165201 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene STK11/NCBI:6794 571 check_entity BB1898-2 STK11 deletion STK11 NCBI:6794 gene cancer MONDO:0004992 PubMed:19541609 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene STK11/NCBI:6794 572 check_entity BB1898-1 STK11 deletion STK11 NCBI:6794 gene lung adenocarcinoma MONDO:0005061 PubMed:20541700 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene STK11/NCBI:6794 571 check_entity BB1899-1 STK11 deletion + KRAS oncogenic mutation STK11 NCBI:6794 gene lung adenocarcinoma MONDO:0005061 PubMed:22425996 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion:+:kras:oncogenic:mutation sequence variation in gene STK11/NCBI:6794 573 check_entity BB1900-1 SUZ12 oncogenic mutation SUZ12 NCBI:23512 gene cancer MONDO:0004992 PubMed:25119042 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene SUZ12/NCBI:23512 574 check_entity BB1901-1 SUZ12 deletion SUZ12 NCBI:23512 gene cancer MONDO:0004992 PubMed:25119042 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene SUZ12/NCBI:23512 575 check_entity BB1902-1 SYK amplification SYK NCBI:6850 gene Mantle cell lymphoma;Chronic lymphocytic leukemia MONDO:0018876 PubMed:16409295 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene SYK/NCBI:6850 576 BB1903-1 TERT promoters core TERT NCBI:7015 gene glioma susceptibility 1 MONDO:0024498 PubMed:25375122 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition TERT promoters core [biomarker_term_in_review] 577 not_mapped BB1904-1 TMPRSS2 fusion TMPRSS2 NCBI:7113 gene prostate adenocarcinoma MONDO:0005082 PubMed:21575865 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::fusion sequence variation in gene TMPRSS2/NCBI:7113 578 check_entity BB1905-1 TOP2A amplification TOP2A NCBI:7153 gene breast adenocarcinoma MONDO:0004988 PubMed:22864769 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:level Increased level of gene TOP2A/NCBI:7153 579 BB1906-1 TP53 oncogenic mutation TP53 NCBI:7157 gene breast adenocarcinoma MONDO:0004988 PubMed:27217383 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene TP53/NCBI:7157 580 check_entity BB1906-2 TP53 oncogenic mutation TP53 NCBI:7157 gene liposarcoma MONDO:0005060 PubMed:23084521 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene TP53/NCBI:7157 581 check_entity BB1906-3 TP53 oncogenic mutation TP53 NCBI:7157 gene ovarian cancer MONDO:0008170 PubMed:27998224 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene TP53/NCBI:7157 582 check_entity BB1906-4 TP53 oncogenic mutation TP53 NCBI:7157 gene Acute myeloid leukemia;Myelodisplasic proliferative syndrome MONDO:0018874 PubMed:27959731 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene TP53/NCBI:7157 583 check_entity BB1906-5 TP53 oncogenic mutation TP53 NCBI:7157 gene childhood bladder carcinoma MONDO:0022578 PubMed:27397505 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene TP53/NCBI:7157 584 check_entity BB1907-1 TP53:R248Q TP53 NCBI:7157 gene cancer MONDO:0004992 PubMed:26009011 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::r248q sequence variation in gene TP53/NCBI:7157 586 check_entity BB1911-2 TSC1 oncogenic mutation TSC1 NCBI:7248 gene Sarcoma;Stomach MONDO:0005089 PubMed:26859683 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene TSC1/NCBI:7248 591 check_entity BB1911-3 TSC1 oncogenic mutation TSC1 NCBI:7248 gene childhood bladder carcinoma MONDO:0022578 PubMed:22923433 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene TSC1/NCBI:7248 592 check_entity BB1911-1 TSC1 oncogenic mutation TSC1 NCBI:7248 gene kidney angiomyolipoma MONDO:0004555 PubMed:23312829 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene TSC1/NCBI:7248 590 check_entity BB1912-2 TSC2 oncogenic mutation TSC2 NCBI:7249 gene childhood bladder carcinoma MONDO:0022578 PubMed:22923433 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene TSC2/NCBI:7249 594 check_entity BB1912-1 TSC2 oncogenic mutation TSC2 NCBI:7249 gene kidney angiomyolipoma MONDO:0004555 PubMed:23312829 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene TSC2/NCBI:7249 593 check_entity BB1912-3 TSC2 oncogenic mutation TSC2 NCBI:7249 gene lymphangioleiomyomatosis MONDO:0011705 PubMed:24691995 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene TSC2/NCBI:7249 595 check_entity BB1913-1 TSC2:E66K TSC2 NCBI:7249 gene endometrial cancer MONDO:0011962 PubMed:27016228 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_I::E66K sequence variation in gene TSC2/NCBI:7249 596 check_entity BB1914-1 TSC2 deletion TSC2 NCBI:7249 gene lymphangioleiomyomatosis MONDO:0011705 PubMed:24691995 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::deletion sequence variation in gene TSC2/NCBI:7249 597 check_entity BB1915-1 TUBB3 overexpression TUBB3 NCBI:10381 gene childhood bladder carcinoma MONDO:0022578 PubMed:23184177 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:increased;aspect_type:expression Increased expression of gene TUBB3/NCBI:10381 598 BB1916-1 U2AF1 oncogenic mutation U2AF1 NCBI:7307 gene cancer MONDO:0004992 PubMed:27397505 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene U2AF1/NCBI:7307 599 check_entity BB1919-1 ZBTB16 undexpression ZBTB16 NCBI:7704 gene prostate adenocarcinoma MONDO:0005082 PubMed:16637071 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition ZBTB16 undexpression [biomarker_term_in_review] 602 not_mapped BB1920-1 ZNRF3 oncogenic mutation ZNRF3 NCBI:84133 gene colorectal adenocarcinoma MONDO:0005008 PubMed:26023187 assessed_biomarker_entity;assessed_biomarker_entity_id;biomarker;condition change_type:presence of;mod_type:sequence variation Presence of bmkb_II::oncogenic:mutation sequence variation in gene ZNRF3/NCBI:84133 603 check_entity